<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="phar70024" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharmacotherapy</journal-id><journal-id journal-id-type="iso-abbrev">Pharmacotherapy</journal-id><journal-id journal-id-type="pmc-domain-id">379</journal-id><journal-id journal-id-type="pmc-domain">blackwellopen</journal-id><journal-id journal-id-type="publisher-id">PHAR</journal-id><journal-title-group><journal-title>Pharmacotherapy</journal-title></journal-title-group><issn pub-type="ppub">0277-0008</issn><issn pub-type="epub">1875-9114</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Wiley Open Access Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12149789</article-id><article-id pub-id-type="pmcid-ver">PMC12149789.1</article-id><article-id pub-id-type="pmcaid">12149789</article-id><article-id pub-id-type="pmcaiid">12149789</article-id><article-id pub-id-type="pmid">40371673</article-id><article-id pub-id-type="doi">10.1002/phar.70024</article-id><article-id pub-id-type="publisher-id">PHAR70024</article-id><article-id pub-id-type="other">12-24-0780.R1</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Review of Therapeutics</subject></subj-group><subj-group subj-group-type="heading"><subject>Review of Therapeutics</subject></subj-group></article-categories><title-group><article-title>Pharmacotherapy research landscape and knowledge gaps of opioids in maternal and pediatric populations</article-title><alt-title alt-title-type="left-running-head">Shendre et&#160;al.</alt-title></title-group><contrib-group><contrib id="phar70024-cr-0001" contrib-type="author" corresp="yes"><name name-style="western"><surname>Shendre</surname><given-names initials="A">Aditi</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4123-7613</contrib-id><xref rid="phar70024-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>shen62@osumc.edu</email></address></contrib><contrib id="phar70024-cr-0002" contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="X">Xiaofu</given-names></name><xref rid="phar70024-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="phar70024-cr-0003" contrib-type="author"><name name-style="western"><surname>Chiang</surname><given-names initials="C">ChienWei</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0988-8478</contrib-id><xref rid="phar70024-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="phar70024-cr-0004" contrib-type="author"><name name-style="western"><surname>Goodwin</surname><given-names initials="A">Andrew</given-names></name><xref rid="phar70024-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="phar70024-cr-0005" contrib-type="author"><name name-style="western"><surname>Oteng</surname><given-names initials="SR">Samuel&#8208;Richard</given-names></name><xref rid="phar70024-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="phar70024-cr-0006" contrib-type="author"><name name-style="western"><surname>Deypalubos</surname><given-names initials="JAF">Jiezel A. F.</given-names></name><xref rid="phar70024-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="phar70024-cr-0007" contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="S">Shijun</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4780-8416</contrib-id><xref rid="phar70024-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="phar70024-cr-0008" contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="L">Lei</given-names></name><xref rid="phar70024-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="phar70024-cr-0009" contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="J">Jianing</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0003-7131-7195</contrib-id><xref rid="phar70024-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="phar70024-cr-0010" contrib-type="author"><name name-style="western"><surname>Abbasi</surname><given-names initials="MY">Mohammad Yaseen</given-names></name><xref rid="phar70024-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="phar70024-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="phar70024-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="phar70024-cr-0011" contrib-type="author"><name name-style="western"><surname>Aruldhas</surname><given-names initials="BW">Blessed Winston</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2082-6454</contrib-id><xref rid="phar70024-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="phar70024-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="phar70024-cr-0012" contrib-type="author"><name name-style="western"><surname>Zaidi</surname><given-names initials="SS">Syed Saoud</given-names></name><xref rid="phar70024-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="phar70024-cr-0013" contrib-type="author"><name name-style="western"><surname>Kirkpatrick</surname><given-names initials="LM">Lindsey Marie</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4689-9950</contrib-id><xref rid="phar70024-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="phar70024-aff-0006" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib id="phar70024-cr-0014" contrib-type="author"><name name-style="western"><surname>Silva</surname><given-names initials="LD">Lais Da</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3649-3292</contrib-id><xref rid="phar70024-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="phar70024-cr-0015" contrib-type="author"><name name-style="western"><surname>Overholser</surname><given-names initials="BR">Brian R.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3055-9916</contrib-id><xref rid="phar70024-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="phar70024-aff-0007" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib id="phar70024-cr-0016" contrib-type="author"><name name-style="western"><surname>O&#8217;Kane</surname><given-names initials="AM">Aislinn M.</given-names></name><xref rid="phar70024-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="phar70024-cr-0017" contrib-type="author"><name name-style="western"><surname>Kannankeril</surname><given-names initials="PJ">Prince J.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1529-9872</contrib-id><xref rid="phar70024-aff-0008" ref-type="aff">
<sup>8</sup>
</xref></contrib><contrib id="phar70024-cr-0018" contrib-type="author"><name name-style="western"><surname>Patrick</surname><given-names initials="SW">Stephen W.</given-names></name><xref rid="phar70024-aff-0009" ref-type="aff">
<sup>9</sup>
</xref></contrib><contrib id="phar70024-cr-0019" contrib-type="author"><name name-style="western"><surname>Wiese</surname><given-names initials="AD">Andrew D.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0699-4224</contrib-id><xref rid="phar70024-aff-0010" ref-type="aff">
<sup>10</sup>
</xref></contrib><contrib id="phar70024-cr-0020" contrib-type="author"><name name-style="western"><surname>Quinney</surname><given-names initials="SK">Sara K.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6554-0695</contrib-id><xref rid="phar70024-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="phar70024-aff-0011" ref-type="aff">
<sup>11</sup>
</xref></contrib><contrib id="phar70024-cr-0021" contrib-type="author" corresp="yes"><name name-style="western"><surname>Li</surname><given-names initials="L">Lang</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0746-1809</contrib-id><xref rid="phar70024-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>lang.li@osumc.edu</email></address></contrib></contrib-group><aff id="phar70024-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Biomedical Informatics, College of Medicine</named-content>
<institution>The Ohio State University Wexner Medical Center</institution>
<city>Columbus</city>
<named-content content-type="country-part">Ohio</named-content>
<country country="US">USA</country>
</aff><aff id="phar70024-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Division of Clinical Pharmacology, Department of Medicine</named-content>
<institution>IUSM</institution>
<city>Indianapolis</city>
<named-content content-type="country-part">Indiana</named-content>
<country country="US">USA</country>
</aff><aff id="phar70024-aff-0003">
<label>
<sup>3</sup>
</label>
<institution>Bouv&#233; College of Health Sciences, Northeastern University</institution>
<city>Boston</city>
<named-content content-type="country-part">Massachusetts</named-content>
<country country="US">USA</country>
</aff><aff id="phar70024-aff-0004">
<label>
<sup>4</sup>
</label>
<institution>Moderna</institution>
<city>Cambridge</city>
<named-content content-type="country-part">Massachusetts</named-content>
<country country="US">USA</country>
</aff><aff id="phar70024-aff-0005">
<label>
<sup>5</sup>
</label>
<institution>Christian Medical College and Hospital</institution>
<city>Vellore</city>
<named-content content-type="country-part">Tamil Nadu</named-content>
<country country="IN">India</country>
</aff><aff id="phar70024-aff-0006">
<label>
<sup>6</sup>
</label>
<named-content content-type="organisation-division">Department of Pediatrics</named-content>
<institution>IUSM</institution>
<city>Indianapolis</city>
<named-content content-type="country-part">Indiana</named-content>
<country country="US">USA</country>
</aff><aff id="phar70024-aff-0007">
<label>
<sup>7</sup>
</label>
<named-content content-type="organisation-division">Department of Pharmacy Practice</named-content>
<institution>Purdue University College of Pharmacy</institution>
<city>West Lafayette</city>
<named-content content-type="country-part">Indiana</named-content>
<country country="US">USA</country>
</aff><aff id="phar70024-aff-0008">
<label>
<sup>8</sup>
</label>
<named-content content-type="organisation-division">Department of Pediatrics</named-content>
<institution>Vanderbilt University Medical Center</institution>
<city>Nashville</city>
<named-content content-type="country-part">Tennessee</named-content>
<country country="US">USA</country>
</aff><aff id="phar70024-aff-0009">
<label>
<sup>9</sup>
</label>
<named-content content-type="organisation-division">Department of Health Policy and Management, Rollins School of Public Health</named-content>
<institution>Emory University</institution>
<city>Atlanta</city>
<named-content content-type="country-part">Georgia</named-content>
<country country="US">USA</country>
</aff><aff id="phar70024-aff-0010">
<label>
<sup>10</sup>
</label>
<named-content content-type="organisation-division">Division of Pharmacoepidemiology, Department of Health Policy</named-content>
<institution>Vanderbilt University Medical Center</institution>
<city>Nashville</city>
<named-content content-type="country-part">Tennessee</named-content>
<country country="US">USA</country>
</aff><aff id="phar70024-aff-0011">
<label>
<sup>11</sup>
</label>
<named-content content-type="organisation-division">Department of Obstetrics and Gynecology, School of Medicine</named-content>
<institution>Indiana University</institution>
<city>Indianapolis</city>
<named-content content-type="country-part">Indiana</named-content>
<country country="US">USA</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Lang Li and Aditi Shendre, 1810 Cannon Dr., Columbus, OH 43210, USA.<break/>
Email: <email>lang.li@osumc.edu</email> and <email>shen62@osumc.edu</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>15</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="ppub"><month>6</month><year>2025</year></pub-date><volume>45</volume><issue seq="80">6</issue><issue-id pub-id-type="pmc-issue-id">490250</issue-id><issue-id pub-id-type="doi">10.1002/phar.v45.6</issue-id><fpage>367</fpage><lpage>385</lpage><history><date date-type="rev-recd"><day>21</day><month>3</month><year>2025</year></date><date date-type="received"><day>13</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>23</day><month>3</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>10</day><month>06</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>11</day><month>06</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-06-11 00:25:15.343"><day>11</day><month>06</month><year>2025</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2025 The Author(s). <italic toggle="yes">Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy</italic> published by Wiley Periodicals LLC on behalf of ACCP Foundation, Ltd.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#8208;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="PHAR-45-367.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:PHAR-45-367.pdf"/><abstract><title>Abstract</title><p>The use and misuse of opioids has surged in the past decade, with nearly half of the users being female. Although opioid use is lower among pregnant women, trends mirror the general population. While pediatric exposures largely occur through prescriptions. This review presents a novel landscape analysis of pharmacology knowledge gaps in opioids in the maternal and pediatric populations. We queried PubMed for studies on 27 opioids, focusing on pharmacokinetics (PK), and pharmacoepidemiology (PE) or clinical trials (CT) in maternal and pediatric populations. English&#8208;language publications were included, and data were synthesized to identify gaps. Additionally, MarketScan claims data and United States Food and Drug Administration (FDA) drug labels were analyzed to compare scientific evidence, opioid prescriptions/orders, and FDA recommendations. Morphine, fentanyl, methadone, and buprenorphine are the most researched opioids in PK and PE/CT literature in both populations, but hydrocodone, oxycodone, and codeine are the most prescribed. Nine opioids lack FDA labels, and four of the 18 labeled drugs lack any human data. Hydrocodone, oxycodone, and codeine labels include lactation&#8208;focused PK information, with some pediatric clinical data for the latter two. Seven opioids lack PK and PE/CT studies in the maternal population, and PK research is absent for seven opioids, and PE/CT data is lacking for eight opioids in the pediatric population. PK studies often focus on labor, delivery, and lactation accompanied by neonatal data, whereas pregnancy research mainly occurs in PE studies. In pediatric populations, study types are evenly distributed among children, but PE studies focus more on adolescents. Drug concentration is the most reported parameter in PK studies, and neonatal opioid withdrawal syndrome (NOWS) is a key outcome in both PK and PE studies. NOWS is also researched more using real&#8208;world data, whereas neurodevelopmental outcomes are often captured in prospective observational studies. There is substantial disparity between the most commonly researched and prescribed opioids. In particular, the opioid pharmacology knowledge gaps are larger in pregnant women and for the highly prescribed opioids hydrocodone and oxycodone. The limited human data in FDA labels underscores the need for additional studies. Studies using real&#8208;world data can potentially help address these gaps.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="phar70024-kwd-0001">biomedical literature</kwd><kwd id="phar70024-kwd-0002">drug labeling</kwd><kwd id="phar70024-kwd-0003">knowledge gaps</kwd><kwd id="phar70024-kwd-0004">maternal</kwd><kwd id="phar70024-kwd-0005">opiates</kwd><kwd id="phar70024-kwd-0006">opioids</kwd><kwd id="phar70024-kwd-0007">pediatric</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
</institution><institution-id institution-id-type="doi">10.13039/100009633</institution-id></institution-wrap></funding-source><award-id>P30HD106451</award-id><award-id>P50HD106446</award-id></award-group></funding-group><counts><fig-count count="5"/><table-count count="8"/><page-count count="19"/><word-count count="10000"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>June 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.7 mode:remove_FC converted:10.06.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="PHAR70024-cit-2001"><string-name name-style="western"><surname>Shendre</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Chiang</surname><given-names>CW</given-names></string-name>, et al. <article-title>Pharmacotherapy research landscape and knowledge gaps of opioids in maternal and pediatric populations</article-title>. <source>Pharmacotherapy</source>. <year>2025</year>;<volume>45</volume>:<fpage>367</fpage>&#8208;<lpage>385</lpage>. doi:<pub-id pub-id-type="doi">10.1002/phar.70024</pub-id><pub-id pub-id-type="pmcid">PMC12149789</pub-id><pub-id pub-id-type="pmid">40371673</pub-id></mixed-citation>
</p></notes></front><body id="phar70024-body-0001"><sec id="phar70024-sec-0001"><label>1</label><title>INTRODUCTION</title><p>The National Survey on Drug Use and Health (NSDUH) in the United States provides annual population estimates on substance use based on a nationally representative sample. In 2022, 8.9&#8201;million respondents reported opioid misuse, 45% of whom were females.<xref rid="phar70024-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref>, <xref rid="phar70024-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> Among females using any prescription opioids in the past year, 10.3% reported misusing them.<xref rid="phar70024-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> Among pregnant women, the rates of opioid use increased from 0.46% to 0.84% between 2006 and 2015, reaching 0.9% in 2018.<xref rid="phar70024-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="phar70024-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> Similarly, misuse rates in pregnant women rose from 0.17% to 0.39% between 1998 and 2011.<xref rid="phar70024-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> The prevalence of opioid misuse was as high as 21.2% in pregnant women, according to the 2019 Pregnancy Risk Assessment Monitoring System (PRAMS) survey conducted by the Centers for Disease Control and Prevention (CDC), while opioid use was lower at 6.6%.<xref rid="phar70024-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>
</p><p>Recent reviews have sought to characterize opioid use patterns, care management, and associated health outcomes during pregnancy but also highlight the limited research on adverse maternal and pediatric outcomes.<xref rid="phar70024-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="phar70024-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>, <xref rid="phar70024-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="phar70024-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> Some outcomes, such as neonatal opioid withdrawal syndrome (NOWS), are well&#8208;documented and studied, while others remain underexplored.<xref rid="phar70024-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="phar70024-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>, <xref rid="phar70024-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> Notably, studies on maternal morbidity and mortality are scarce and are often secondary to pediatric&#8208;focused outcomes.<xref rid="phar70024-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="phar70024-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="phar70024-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> Although neonates are subject to prenatal exposures, children and adolescents are predominantly exposed through prescriptions.<xref rid="phar70024-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> Opioids in pediatric patients are commonly prescribed for surgeries or dental procedures, with a 2019 study reporting prescription rates as high as 61.4% based on longitudinal pharmacy data.<xref rid="phar70024-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>
</p><p>Although research in maternal and pediatric populations has increased in recent years, these groups have been historically understudied, particularly in clinical trials (CTs).<xref rid="phar70024-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="phar70024-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> Physiological changes during pregnancy necessitate the evaluation of drug pharmacologic effects through pharmacokinetics (PK) studies, and existing PK research on some opioids provides useful data, but PK has inherent design constraints.<xref rid="phar70024-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>, <xref rid="phar70024-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> Pediatric PK opioid research has expanded as well but shows high variability across distinct age groups.<xref rid="phar70024-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> These limitations underscore the need for innovative approaches to address the unique needs of these sensitive populations.</p><p>The use of real&#8208;world data (RWD) like medical claims or electronic health records (EHR) has significantly facilitated the recent rise in research in these once excluded groups.<xref rid="phar70024-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="phar70024-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="phar70024-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="phar70024-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>, <xref rid="phar70024-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref> These pharmacoepidemiologic (PE) studies have been instrumental in filling knowledge gaps and generating evidence that can be used to not only inform safe prescribing practices but also promote drug development in these demographics.<xref rid="phar70024-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> To this end, the goal of the Maternal and Pediatric Precision in Therapeutics Data and Model Knowledge and Research Coordination Center (MPRINT&#8208;DMKRCC, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://mprint.org/" ext-link-type="uri">https://mprint.org/</ext-link>) has been to create and develop an MPRINT Knowledgebase (KB) that will include curated pharmacologic data from PK, PE, and CT studies in maternal and pediatric populations.<xref rid="phar70024-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>
</p><p>The aim of this review was to map the pharmacotherapy research landscape of PK and PE/CT studies on opioids in maternal and pediatric populations. To complement this analysis, we examined prescription/order rates using a sample of Merative MarketScan commercial claims data (hereafter referred to as MarketScan).<xref rid="phar70024-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> Additionally, we analyzed United States Food and Drug Administration (FDA) labels, focusing on population&#8208;specific sections to assess the availability of information and human data underlying their recommendations.</p></sec><sec sec-type="methods" id="phar70024-sec-0002"><label>2</label><title>METHODS</title><sec id="phar70024-sec-0003"><label>2.1</label><title>Drug selection</title><p>Opioids were identified using the Anatomical Therapeutic Chemical (ATC) classification system<xref rid="phar70024-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> and the codes: N02A (opioids), N01AH (opioid anesthetics), and R05DA (opium alkaloids and derivatives, cough suppressants). Levorphanol, the only opioid without an ATC code, was also included, while antagonists were excluded. The 27 opioids selected are listed in Table&#160;<xref rid="phar70024-supitem-0001" ref-type="supplementary-material">S1</xref>.</p></sec><sec id="phar70024-sec-0004"><label>2.2</label><title>Subpopulation categories</title><p>The maternal population was divided into the following subsets. (i) pregnant/pregnancy &#8211; studies during pregnancy or reporting opioid use across any trimester, (ii) labor/delivery &#8211; any opioids that were used or given during the labor or delivery period, including the immediate postoperative period for women undergoing cesarean section, (iii) postpartum &#8211; studies covering 6&#8211;8&#8201;weeks post&#8208;delivery, excluding lactation&#8208;focused research, (iv) lactation &#8211; studies focused on nursing, breastfeeding, or lactation, and (v) fetal/fetus &#8211; considered jointly with maternal studies due to dependence on the mother.</p><p>The pediatric population was divided into the following subsets. (i) preterm &#8211; birth at &#8804;37&#8201;weeks of gestation, (ii) newborn/neonate &#8211; the first 0 to 28&#8201;days of life, (iii) infant &#8211; &gt;28&#8201;days up to 1&#8201;year of life, (iv) children &#8211; &gt;1&#8201;year up to 12&#8201;years old, and (v) adolescent &#8211; &gt;12 up to 21&#8201;years old.<xref rid="phar70024-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> For simplicity, the toddler and childhood stages were combined together into &#8220;children.&#8221;</p></sec><sec id="phar70024-sec-0005"><label>2.3</label><title>Literature search strategy</title><p>PubMed was queried using the following search string &#8208; &#8220;opioids AND [population type] AND [study type] NOT animals NOT reviews,&#8221;, limiting it to humans and original publications. Population terms included pregnancy, postpartum, lactation, neonate, and pediatric. Pharmacokinetics (PK) and pharmacoepidemiology/epidemiology (PE) were used to specify study type. The search was initially conducted in June 2022 followed by an updated search in September 2022. Additionally, non&#8208;compartmental PK studies from an alternative modeling&#8208;focused search were also included to ensure completeness, but PK modeling studies were not included in our review (details in Appendix&#8201;<xref rid="phar70024-supitem-0001" ref-type="supplementary-material">S1</xref>). Titles and abstracts retrieved were screened by A.S.</p><sec id="phar70024-sec-0006"><label>2.3.1</label><title>Initial abstract screening and data extraction</title><p>Eligibility was determined based on the criteria specified in Table&#160;<xref rid="phar70024-tbl-0001" ref-type="table">1</xref>. Clinical trials were classified separately after the initial screen as they comprised approximately one&#8208;fourth of the publications retrieved using PE search terms. The full text for the relevant publications was collected for data extraction after this initial review. Relevant information from each study type was extracted with the data elements specified in Table&#160;<xref rid="phar70024-tbl-0002" ref-type="table">2</xref>.</p><table-wrap position="float" id="phar70024-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Inclusion/exclusion criteria for selection of publications related to opioids in the maternal and pediatric populations.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Criteria</th><th align="left" valign="bottom" rowspan="1" colspan="1">Pharmacokinetics</th><th align="left" valign="bottom" rowspan="1" colspan="1">Pharmacoepidemiology or clinical trials</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Inclusion</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="bullet" id="phar70024-list-0001"><list-item id="phar70024-li-0001"><p>Non&#8208;combination drug studies</p></list-item><list-item id="phar70024-li-0002"><p>Drug interaction studies</p></list-item><list-item id="phar70024-li-0003"><p>Clinical</p></list-item><list-item id="phar70024-li-0004"><p>Non&#8208;compartmental</p></list-item><list-item id="phar70024-li-0005"><p>Individual or summary&#8208;level values for PK parameters are available</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="bullet" id="phar70024-list-0002"><list-item id="phar70024-li-0006"><p>Drugs as the primary exposure or intervention</p></list-item><list-item id="phar70024-li-0007"><p>Outcomes associated with the primary drug</p></list-item><list-item id="phar70024-li-0008"><p>Prospective or retrospective</p></list-item><list-item id="phar70024-li-0009"><p>Quantitative</p></list-item></list>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Exclusion</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="bullet" id="phar70024-list-0003"><list-item id="phar70024-li-0010"><p>In vitro studies</p></list-item><list-item id="phar70024-li-0011"><p>Animal studies</p></list-item><list-item id="phar70024-li-0012"><p>Physiologically based PK studies</p></list-item><list-item id="phar70024-li-0013"><p>Population PK studies</p></list-item><list-item id="phar70024-li-0014"><p>Other PK modeling or pharmacometrics studies</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="bullet" id="phar70024-list-0004"><list-item id="phar70024-li-0015"><p>Studies where the drug was a secondary exposure</p></list-item><list-item id="phar70024-li-0016"><p>Qualitative</p></list-item><list-item id="phar70024-li-0017"><p>Medication frequency, drug prevalence, or patterns of drug use</p></list-item><list-item id="phar70024-li-0018"><p>Case reports</p></list-item><list-item id="phar70024-li-0019"><p>Patient/hospital usability studies</p></list-item><list-item id="phar70024-li-0020"><p>Patient/provider engagement studies</p></list-item><list-item id="phar70024-li-0021"><p>Data mining of registry or health records</p></list-item></list>
</td></tr></tbody></table></table-wrap><table-wrap position="float" id="phar70024-tbl-0002" content-type="TABLE" orientation="portrait"><label>TABLE 2</label><caption><p>Data elements extracted from the opioid publications based on study types.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Common data elements</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="bullet" id="phar70024-list-0005"><list-item id="phar70024-li-0022"><p>Drug names/classes</p></list-item><list-item id="phar70024-li-0023"><p>Population type</p></list-item><list-item id="phar70024-li-0024"><p>Pregnancy stage or gestational age</p></list-item><list-item id="phar70024-li-0025"><p>Age for pediatric population classification</p></list-item></list>
</td></tr></tbody></table><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" colspan="2" valign="bottom" rowspan="1">Study specific data elements</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Pharmacokinetics 
<list list-type="bullet" id="phar70024-list-0006"><list-item id="phar70024-li-0026"><p>PK parameters</p></list-item><list-item id="phar70024-li-0027"><p>Pharmacodynamic/clinical endpoints</p></list-item><list-item id="phar70024-li-0028"><p>Specimen information: type of sample and sampling method</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">Pharmacoepidemiology or clinical trials
<list list-type="bullet" id="phar70024-list-0007"><list-item id="phar70024-li-0029"><p>Study information
<list list-type="bullet" id="phar70024-list-0008"><list-item id="phar70024-li-0030"><p>Study design</p></list-item><list-item id="phar70024-li-0031"><p>Data sources</p></list-item><list-item id="phar70024-li-0032"><p>Reported outcomes</p></list-item></list>
</p></list-item><list-item id="phar70024-li-0033"><p>Outcome&#8208;related parameters
<list list-type="bullet" id="phar70024-list-0009"><list-item id="phar70024-li-0034"><p>Population characteristics/risk factors</p></list-item><list-item id="phar70024-li-0035"><p>Drug exposures</p></list-item><list-item id="phar70024-li-0036"><p>Outcome definition</p></list-item></list>
</p></list-item></list>
</td></tr></tbody></table></table-wrap></sec><sec id="phar70024-sec-0007"><label>2.3.2</label><title>Statistical analysis</title><p>We performed a descriptive analysis to report publication frequencies for each of the opioid drugs as well as the different subpopulations with respect to PK and PE/CT studies. The initial analysis focused on estimating publication frequencies for each opioid by PK and PE/CT studies, respectively. The next stage incorporated subpopulation information to determine if any studies have been conducted for each opioid drug within each subpopulation for the PK and PE/CT studies.</p><p>The PK&#8208;specific analyses included identifying and calculating the publication frequencies for the different PK parameters reported, clinical endpoints measured, and types of specimens sampled along with their sampling frequencies. Specimens in the PK studies were sampled at different frequencies and time points. Based on a combination of both, we categorized the sampling frequencies into four types: (i) intensive sampling with several samples collected within a couple of days, (ii) sparse sampling with one sample collected per subject, (iii) cross&#8208;over referring to multiple samples per subject collected across different time periods, (iv) cross&#8208;sectional referring to one sample per subject collected across different time periods, and (v) case study, indicating whether PK information is available at the individual or sample level.</p><p>The PE/CT&#8208;specific analyses included identifying and calculating the publication frequencies for the type of study &#8211; PE or CT as well as PE study designs such as retrospective, prospective, and others (cross&#8208;sectional, longitudinal, case&#8211;control). Next, risk factors associated with the outcomes and frequently reported in PE/CT studies were determined. Finally, relevant primary as well as secondary health outcomes reported in the PE/CT studies were identified and evaluated. Because of the innumerable and varied outcomes reported in the publications, we created broad categories that would encompass outcomes related to the different subpopulations, including maternal, birth, pediatric, opioid&#8208;specific, and health care utilization outcomes.</p><p>Additionally, we differentiated the outcomes by data sources &#8211; those collected from administrative/EHR data versus non&#8208;administrative/EHR data. Administrative/EHR data are also called RWD and are routinely collected in relation to a patient's health status or delivery of health care.<xref rid="phar70024-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> On the other hand, PE/CT studies that involve active prospective data collection from the patients or enrollees of the study are considered non&#8208;RWD. The total number of studies based on administrative/EHR data was 228, and the non&#8208;administrative/EHR category included the remainder of the PE studies (<italic toggle="yes">n</italic>&#8201;=&#8201;273). We did not include CT studies since the design and conduct of these trials are unlike PE studies. In this analysis, we investigated which health outcomes are more likely to be studied between the two data sources for all opioid drugs combined. The results are presented as the proportion of studies reporting one or more outcomes to the total number of studies within each data source. We tested the difference between the two using the <italic toggle="yes">z</italic>&#8208;score and two&#8208;tailed test for two proportions at a significance level of 0.05 using the NORM.S.DIST function in Microsoft Excel (Redmond, WA).</p></sec></sec><sec id="phar70024-sec-0008"><label>2.4</label><title>Opioid prescription/order rate analysis</title><p>The Merative MarketScan commercial claims database was utilized to determine prescription/order rates among pregnant and pediatric enrollees between 2016 and 2021.<xref rid="phar70024-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> In brief, MarketScan is one of the largest and longest&#8208;running US claims databases and captures detailed, de&#8208;identified claims data on clinical utilization, expenditures, and enrollment. These data span inpatient, outpatient, prescription drug, and other healthcare services providing a comprehensive view of real&#8208;world healthcare usage as well as clinical outcomes.</p><p>Our analysis included pregnant enrollees if they had at least one delivery and/or procedure code (Table&#160;<xref rid="phar70024-supitem-0001" ref-type="supplementary-material">S2</xref>). The date associated with the first delivery code was defined as the index date, and only those enrollees who were continuously enrolled for 270&#8201;days before and 180&#8201;days after the index date were included. Any opioid&#8208;related prescriptions/orders between 270&#8201;days before and 180&#8201;days after the index date were counted. Pediatric enrollees were included if they were in the following age groups during the 5&#8208;year period&#8211; neonates/infants (0&#8211;1&#8201;years), children (1&#8211;12&#8201;years), and adolescents (13&#8211;18&#8201;years). Opioid prescriptions/orders during those 5&#8201;years were counted cumulatively for each drug and age group. The proportion of patients given an opioid was then calculated for each drug by dividing it by the total number of patients enrolled during the 5&#8208;year period in each subpopulation. Opioids prescribed in the outpatient setting are labeled &#8220;outpatient prescriptions,&#8221; and those ordered during an outpatient or inpatient procedure are labeled &#8220;outpatient/inpatient orders.&#8221; The rates for the prescriptions and orders were calculated separately.</p></sec><sec id="phar70024-sec-0009"><label>2.5</label><title>
<styled-content style="fixed-case" toggle="no">FDA</styled-content> drug label analysis</title><p>Labels for the opioid drugs were downloaded from the FDA's website.<xref rid="phar70024-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref> The information on active ingredients was obtained from three different components: openfda_substance_name, active_ingredient, and spl_product_data_elements. Only those FDA labels with a single active ingredient were selected for further analysis. The labels with the individual opioids as core ingredients and the corresponding maternal and pediatric medication information were then extracted and organized to conduct descriptive analysis. The labels were considered to have information on maternal and pediatric populations if the sections under those categories had any text, regardless of the content presented in the text. Analysis to determine if data from human studies were present in the labels was conducted manually, with only a single version and formulation of the FDA label used for each of the opioids.</p></sec></sec><sec sec-type="results" id="phar70024-sec-0010"><label>3</label><title>RESULTS</title><p>Table&#160;<xref rid="phar70024-tbl-0003" ref-type="table">3</xref> presents the number of opioid publications initially retrieved and eventually retained for the maternal and pediatric populations and the PK and PE/CT studies, respectively. Statistics based on the final curated publications are presented below, separated by study types. Since studies may evaluate or report on more than one drug or population, the frequencies presented below may not add up to the total number of publications retained.</p><table-wrap position="float" id="phar70024-tbl-0003" content-type="TABLE" orientation="portrait"><label>TABLE 3</label><caption><p>Number of opioid publications retrieved from PubMed and retained based on our inclusion/exclusion criteria.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Study and population types</th><th align="left" valign="bottom" rowspan="1" colspan="1">Number of retrieved publications</th><th align="left" valign="bottom" rowspan="1" colspan="1">Number of retained publications</th></tr></thead><tbody valign="top"><tr><td align="left" colspan="3" valign="top" rowspan="1">Pharmacokinetic studies</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Maternal</td><td align="char" char="." valign="top" rowspan="1" colspan="1">220</td><td align="char" char="." valign="top" rowspan="1" colspan="1">147</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Pediatrics</td><td align="char" char="." valign="top" rowspan="1" colspan="1">399</td><td align="char" char="." valign="top" rowspan="1" colspan="1">135</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Total</td><td align="char" char="." valign="top" rowspan="1" colspan="1">619</td><td align="char" char="." valign="top" rowspan="1" colspan="1">282</td></tr><tr><td align="left" colspan="3" valign="top" rowspan="1">Pharmacoepidemiology studies or clinical trials</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Maternal</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1018</td><td align="char" char="." valign="top" rowspan="1" colspan="1">328</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Pediatrics</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1033</td><td align="char" char="." valign="top" rowspan="1" colspan="1">320</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Total</td><td align="char" char="." valign="top" rowspan="1" colspan="1">2051</td><td align="char" char="." valign="top" rowspan="1" colspan="1">648</td></tr></tbody></table></table-wrap><sec id="phar70024-sec-0011"><label>3.1</label><title>Pharmacokinetic (<styled-content style="fixed-case" toggle="no">PK</styled-content>) studies</title><p>A total of 282 PK publications were curated. The rest of the publications were excluded after full&#8208;text review because of studies with unrelated population types or drugs, studies focusing on assay development, ontogeny, binding or transporter enzymes, modeling/pharmacometrics, no PK parameter values, non&#8208;English publications, reviews/opinions/commentaries/letters to the editor, or lack of access to full text.</p><p>Of the 27 opioids, 23 opioids had PK studies that were relevant to our populations and could be curated for PK parameters (Figure&#160;<xref rid="phar70024-fig-0001" ref-type="fig">1A</xref>). Among these, morphine (<italic toggle="yes">n</italic>&#8201;=&#8201;78) was the most frequently studied drug, followed by fentanyl (<italic toggle="yes">n</italic>&#8201;=&#8201;47), and methadone (<italic toggle="yes">n</italic>&#8201;=&#8201;36). Drugs with only a single study reporting any PK data were found for oxymorphone and dihydrocodeine. Opioids with less than five studies (but more than one study) included butorphanol, ketobemidone, meptazinol, nalbuphine, pentazocine, piritramide, propoxyphene, and tapentadol. Drugs noted to have no PK studies were dextropropoxyphene, levorphanol, phenazocine, and phenoperidine. Among the published PK studies, 89.9% reported PK parameter information for the parent drug, with 35.6% of these studies also presenting information on one or more metabolites, while 4.4% of the studies focused on an analyte other than the parent drug. The rest presented data in the form of relevant figures such as concentration&#8208;time curves.</p><fig position="float" fig-type="FIGURE" id="phar70024-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>Number of pharmacokinetics (A) and pharmacoepidemiology/clinical trial publications (B) for each opioid.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="PHAR-45-367-g003.jpg"/></fig><p>When the individual opioid drugs are evaluated further by the maternal and pediatric subpopulations (Figure&#160;<xref rid="phar70024-fig-0002" ref-type="fig">2A</xref>), the distribution of the PK publications is varied. On the one hand, morphine, methadone, and fentanyl were studied across all maternal and pediatric subpopulations. In contrast, only one study reported PK parameters for meptazinol in the pregnant and neonatal populations, respectively. Similarly, dihydrocodeine concentrations were reported for a neonate and a 14&#8208;year&#8208;old in a single case report. Additionally, only eight different opioids have any PK studies in the pregnant and adolescent populations and six different opioids in the postpartum and preterm populations, respectively.</p><fig position="float" fig-type="FIGURE" id="phar70024-fig-0002" orientation="portrait"><label>FIGURE 2</label><caption><p>Knowledge gaps in pharmacokinetics (A) and pharmacoepidemiology/clinical trials (B) research by population types for each opioid. White &#8211; no publications, dark gray &#8211; 1+ publications.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="PHAR-45-367-g002.jpg"/></fig><p>We noted that drug concentration (<italic toggle="yes">n</italic>&#8201;=&#8201;223) was the most reported parameter in the PK studies, followed by clearance (<italic toggle="yes">n</italic>&#8201;=&#8201;93) and half&#8208;life (<italic toggle="yes">n</italic>&#8201;=&#8201;83) (Figure&#160;<xref rid="phar70024-fig-0003" ref-type="fig">3A</xref>). PK parameters unique to the maternal and pediatric populations included fetal&#8208;maternal ratio, milk&#8208;to&#8208;plasma ratio, and estimated infant dose from breast milk concentrations. Many PK studies also report clinical endpoints, with the top reported endpoint being the opioid&#8208;specific NOWS (<italic toggle="yes">n</italic>&#8201;=&#8201;54) among neonates, followed by opioid&#8208;related side effects (<italic toggle="yes">n</italic>&#8201;=&#8201;49) in either the maternal or pediatric populations (Figure&#160;<xref rid="phar70024-fig-0003" ref-type="fig">3B</xref>).</p><fig position="float" fig-type="FIGURE" id="phar70024-fig-0003" orientation="portrait"><label>FIGURE 3</label><caption><p>Distribution of parameters (A) and clinical endpoints (B) reported in the opioid pharmacokinetics (PK) publications.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-5" orientation="portrait" xlink:href="PHAR-45-367-g005.jpg"/></fig><p>Figure&#160;<xref rid="phar70024-fig-0004" ref-type="fig">4A</xref> shows the number of publications that used the different sampling techniques in the two population types. Among these, the most noted was intensive sampling, followed by case study, then sparse sampling. All three were higher in the pediatric population compared to the maternal population. Cross&#8208;over and cross&#8208;sectional were the least common sampling methods but were noted more in the maternal than pediatric populations. Additionally, we also collected information on the type of specimen used, the most common being blood in both populations, either in the form of plasma or serum (pediatric&#8201;=&#8201;45.7%, maternal&#8201;=&#8201;36.2%), followed by urine (<italic toggle="yes">n</italic>&#8201;=&#8201;13.5%), and then breast milk (<italic toggle="yes">n</italic>&#8201;=&#8201;10.6%) (Figure&#160;<xref rid="phar70024-fig-0004" ref-type="fig">4B</xref>).</p><fig position="float" fig-type="FIGURE" id="phar70024-fig-0004" orientation="portrait"><label>FIGURE 4</label><caption><p>Sampling frequencies (A) and specimen types (B) used in the opioid pharmacokinetics studies.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-7" orientation="portrait" xlink:href="PHAR-45-367-g004.jpg"/></fig></sec><sec id="phar70024-sec-0012"><label>3.2</label><title>Pharmacoepidemiologic studies or clinical trials</title><p>A total of 648 PE/CT opioid publications were curated, with the rest of the publications excluded based on criteria similar to those listed under PK study results. PE/CT studies were distributed across 23 different opioid drugs and two additional categories, including any/all opioids and illicit opioids (Figure&#160;<xref rid="phar70024-fig-0001" ref-type="fig">1B</xref>). Among individual opioids, methadone (<italic toggle="yes">n</italic>&#8201;=&#8201;183) was studied the most but was followed by publications that included any/all opioids (<italic toggle="yes">n</italic>&#8201;=&#8201;160) in their studies. Some of the least studied drugs included ketobemidone (<italic toggle="yes">n</italic>&#8201;=&#8201;3), butorphanol (<italic toggle="yes">n</italic>&#8201;=&#8201;2), dextropropoxyphene (<italic toggle="yes">n</italic>&#8201;=&#8201;1), and piritramide (<italic toggle="yes">n</italic>&#8201;=&#8201;1). Other drugs with only four publications included alfentanil, dihydrocodeine, propoxyphene, and tapentadol. There are four opioid drugs that have no PE/CT publications, including levorphanol, meptazinol, phenazocine, and phenoperidine. The use of one or more illicit substances was also captured and represented about 15% of the PE/CT curated studies.</p><p>When we evaluate the publication distributions by the maternal and pediatric subpopulations (Figure&#160;<xref rid="phar70024-fig-0002" ref-type="fig">2B</xref>), the PE/CT knowledge gaps among opioids are very diverse. Although methadone, buprenorphine, fentanyl, and meperidine have been studied in all subpopulations, some drugs have been evaluated only in a single population, such as oxymorphone and propoxyphene in pregnant women, butorphanol during labor/delivery, dextropropoxyphene in newborns/neonates, and piritramide in children.</p><p>Among all the curated PE/CT studies across both populations, 22.5% were clinical trials and 77.5% were PE studies. Among PE studies, 65.1% were retrospective, followed by prospective (27.3%), with mixed/other study designs comprising the remaining 7.6%. Some other studies that specified their study designs and were curated as such included cross&#8208;sectional (6.8%), longitudinal cohort (5.8%), and case&#8211;control (4.6%).</p><sec id="phar70024-sec-0013"><label>3.2.1</label><title>Risk factors</title><p>Table&#160;<xref rid="phar70024-tbl-0004" ref-type="table">4</xref> presents publication frequencies for risk factors associated with outcomes in PE/CT studies. The most curated ones include concomitant drugs (<italic toggle="yes">n</italic>&#8201;=&#8201;149), followed by comorbidities (<italic toggle="yes">n</italic>&#8201;=&#8201;99) such as chronic hypertension, diabetes, infections, or other organ disease. Other risk factors captured include demographics (age, race/ethnicity, sex), tobacco/alcohol use, social determinants of health, time or trend analysis, and genetics.</p><table-wrap position="float" id="phar70024-tbl-0004" content-type="TABLE" orientation="portrait"><label>TABLE 4</label><caption><p>Frequency of risk factors associated with pharmacoepidemiology/clinical trial outcomes in maternal and pediatric populations.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Risk factors</th><th align="left" valign="bottom" rowspan="1" colspan="1">Publications, <italic toggle="yes">n</italic>
</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Concomitant drugs</td><td align="char" char="." valign="top" rowspan="1" colspan="1">149</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Comorbidities</td><td align="char" char="." valign="top" rowspan="1" colspan="1">99</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age</td><td align="char" char="." valign="top" rowspan="1" colspan="1">81</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Social determinants of health</td><td align="char" char="." valign="top" rowspan="1" colspan="1">54</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Time period/trend analysis</td><td align="char" char="." valign="top" rowspan="1" colspan="1">49</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tobacco/alcohol use</td><td align="char" char="." valign="top" rowspan="1" colspan="1">47</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Race/ethnicity</td><td align="char" char="." valign="top" rowspan="1" colspan="1">44</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sex</td><td align="char" char="." valign="top" rowspan="1" colspan="1">36</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Genetics</td><td align="char" char="." valign="top" rowspan="1" colspan="1">14</td></tr></tbody></table></table-wrap></sec><sec id="phar70024-sec-0014"><label>3.2.2</label><title>Health outcomes</title><p>Table&#160;<xref rid="phar70024-tbl-0005" ref-type="table">5</xref> presents the proportion of studies reporting one or more PE outcomes by their respective data source. Among maternal outcomes, all of the studies were reported similarly across RWD and non&#8208;RWD. On the other hand, some birth outcomes were captured significantly differently between RWD and non&#8208;RWD. NOWS, preterm birth, and small for gestational age or low birth weight outcomes were significantly greater in RWD studies, whereas Apgar score was reported more in the non&#8208;RWD studies. Other outcomes like death or distress of the fetus or newborn, birth defects or congenital anomalies, and breastfeeding were reported similarly across both RWD and non&#8208;RWD sources. Neurodevelopmental or behavioral conditions are pediatric outcomes that were more likely to be studied in non&#8208;RWD, whereas circulatory effects of the opioids were more prevalent in RWD studies. All other pediatric outcomes, including respiratory, cardiac, or bleeding effects and sleep disorders, have been studied similarly using both RWD and non&#8208;RWD.</p><table-wrap position="float" id="phar70024-tbl-0005" content-type="TABLE" orientation="portrait"><label>TABLE 5</label><caption><p>Relative frequency of outcomes related to opioids in the maternal and pediatric populations using real&#8208;world data in pharmacoepidemiology publications.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Outcomes</th><th align="left" valign="bottom" rowspan="1" colspan="1">Administrative/EHR, %</th><th align="left" valign="bottom" rowspan="1" colspan="1">Non&#8208;administrative/EHR, %</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#8208;Value</th></tr></thead><tbody valign="top"><tr><td align="left" colspan="4" valign="top" rowspan="1">
<bold>
<sans-serif>Maternal outcomes</sans-serif>
</bold>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Maternal substance use/urine drug screen</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>11.8</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>10.6</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>0.667</sans-serif>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Labor/delivery outcomes</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>7.5</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>5.9</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>0.472</sans-serif>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Perinatal morbidity</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>7.0</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>5.9</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>0.596</sans-serif>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Maternal mortality</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>6.6</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>4.0</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>0.201</sans-serif>
</td></tr><tr><td align="left" colspan="4" valign="top" rowspan="1">
<bold>
<sans-serif>Birth outcomes</sans-serif>
</bold>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Neonatal opioid withdrawal syndrome</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>45.2</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>35.9</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<bold>
<sans-serif>0.035</sans-serif>
</bold>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Preterm birth</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>25.9</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>17.6</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<bold>
<sans-serif>0.024</sans-serif>
</bold>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Small for gestational age/low birth weight</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>20.2</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>9.9</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<bold>
<sans-serif>0.001</sans-serif>
</bold>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Breast feeding information</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>14.5</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>10.6</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>0.194</sans-serif>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Apgar score</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>10.5</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>21.2</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<bold>
<sans-serif>0.001</sans-serif>
</bold>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Birth defects/congenital anomalies</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>9.6</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>7.7</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>0.435</sans-serif>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Neonatal/infant mortality</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>8.3</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>8.1</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>0.912</sans-serif>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Miscarriage/stillborn/intrauterine growth restriction/demise</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>6.1</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>5.9</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>0.897</sans-serif>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Respiratory distress syndrome</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>4.4</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>3.3</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>0.522</sans-serif>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Fetal distress</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>3.1</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>2.2</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>0.542</sans-serif>
</td></tr><tr><td align="left" colspan="4" valign="top" rowspan="1">
<bold>
<sans-serif>Pediatric outcomes</sans-serif>
</bold>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Respiratory effects</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>11.0</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>8.1</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>0.267</sans-serif>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Neurodevelopmental/behavioral outcomes</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>7.0</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>13.2</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<bold>
<sans-serif>0.024</sans-serif>
</bold>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Cardiac effects</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>4.8</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>4.8</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>0.976</sans-serif>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Circulatory effects</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>3.1</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>0.4</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<bold>
<sans-serif>0.016</sans-serif>
</bold>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Bleeding effects</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>2.2</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>2.2</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>1.000</sans-serif>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Sleep disorders</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>1.3</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>2.9</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>0.219</sans-serif>
</td></tr><tr><td align="left" colspan="4" valign="top" rowspan="1">
<bold>
<sans-serif>Opioid&#8208;specific outcomes</sans-serif>
</bold>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Opioid dose information</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>16.2</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>24.5</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<bold>
<sans-serif>0.023</sans-serif>
</bold>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Overdose</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>12.3</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>3.3</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<bold>
<sans-serif>&lt;0.001</sans-serif>
</bold>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Analgesia outcomes/satisfaction</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>10.1</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>13.6</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>0.234</sans-serif>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Respiratory depression</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>7.5</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>10.3</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>0.276</sans-serif>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Pruritus</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>3.9</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>4.8</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>0.659</sans-serif>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Nausea or vomiting</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>2.6</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>7.7</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<bold>
<sans-serif>0.012</sans-serif>
</bold>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Somnolence</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>2.6</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>2.6</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>0.960</sans-serif>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Sedation</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>0.9</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>4.8</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<bold>
<sans-serif>0.011</sans-serif>
</bold>
</td></tr><tr><td align="left" colspan="4" valign="top" rowspan="1">
<bold>
<sans-serif>Healthcare utilization outcomes</sans-serif>
</bold>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Length of hospital stay</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>25.0</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>21.6</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>0.368</sans-serif>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Admission/readmission</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>15.8</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>11.4</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>0.147</sans-serif>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>Hospital discharge</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>8.8</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>9.2</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>0.881</sans-serif>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<sans-serif>ED/hospital/clinic visit</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>8.8</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<sans-serif>4.0</sans-serif>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<bold>
<sans-serif>0.029</sans-serif>
</bold>
</td></tr></tbody></table><table-wrap-foot id="phar70024-ntgp-0101"><fn id="phar70024-note-1001"><p>
<italic toggle="yes">Note</italic>: <italic toggle="yes">p</italic>&#8208;Values&#8201;&lt;&#8201;0.05 are shown in bold.</p></fn><fn id="phar70024-note-0102"><p>Abbreviations: ED: Emergency Department; EHR: Electronic Health Records.</p></fn></table-wrap-foot></table-wrap><p>For opioid&#8208;specific outcomes, overdose was reported significantly more often in RWD studies, whereas opioid dose information, nausea or vomiting, and sedation were reported significantly more often in non&#8208;RWD studies. The remaining opioid&#8208;specific side effects were also more likely to be reported in non&#8208;RWD studies, although the difference between RWD and non&#8208;RWD studies was not significant. Health care utilization outcomes, such as length of hospital stay, admission/readmission, and hospital discharge, were studied in both RWD and non&#8208;RWD, whereas ED, hospital, or clinic visits were reported more often in RWD studies.</p></sec></sec><sec id="phar70024-sec-0015"><label>3.3</label><title>Opioid prescription/order rates</title><p>Table&#160;<xref rid="phar70024-tbl-0006" ref-type="table">6</xref> presents the prescription/order rates for 18 opioids in the maternal and pediatric populations from the MarketScan commercial claims database between 2016 and 2021. The total number of enrollees in the maternal population from 2016 to 2021 was 729,524. The highest prescriptions were noted for oxycodone (22.8%) followed by hydrocodone (13.7%) in the postpartum period. Codeine and tramadol were two other drugs prescribed to &gt;1% of the maternal population in the postpartum period. Hydrocodone was prescribed at a slightly higher rate (3.6%) than codeine (2.9%) or oxycodone (2.2%) during pregnancy, but all rates were lower compared to the postpartum period. Buprenorphine was prescribed to 1.1% of the maternal population during pregnancy.</p><table-wrap position="float" id="phar70024-tbl-0006" content-type="TABLE" orientation="portrait"><label>TABLE 6</label><caption><p>Prescription/order rates (%) for 18 opioids in the maternal and pediatric populations using the Merative MarketScan commercial claims data from 2016 to 2021.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="4" valign="bottom" colspan="1">Drug name</th><th align="left" colspan="6" valign="bottom" rowspan="1">Maternal</th><th align="left" colspan="6" valign="bottom" rowspan="1">Pediatric</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" colspan="2" valign="bottom" rowspan="1">Pregnancy</th><th align="left" colspan="2" valign="bottom" rowspan="1">Labor/Delivery</th><th align="left" colspan="2" valign="bottom" rowspan="1">Postpartum</th><th align="left" colspan="2" valign="bottom" rowspan="1">Neonates/Infants</th><th align="left" colspan="2" valign="bottom" rowspan="1">Children</th><th align="left" colspan="2" valign="bottom" rowspan="1">Adolescents</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" colspan="2" valign="bottom" rowspan="1">
<italic toggle="yes">N</italic>&#8201;=&#8201;729,524</th><th align="left" colspan="2" valign="bottom" rowspan="1">
<italic toggle="yes">N</italic>&#8201;=&#8201;729,524</th><th align="left" colspan="2" valign="bottom" rowspan="1">
<italic toggle="yes">N</italic>&#8201;=&#8201;729,524</th><th align="left" colspan="2" valign="bottom" rowspan="1">
<italic toggle="yes">N</italic>&#8201;=&#8201;2,828,907</th><th align="left" colspan="2" valign="bottom" rowspan="1">
<italic toggle="yes">N</italic>&#8201;=&#8201;22,172,458</th><th align="left" colspan="2" valign="bottom" rowspan="1">
<italic toggle="yes">N</italic>&#8201;=&#8201;9,995,976</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Outpatient prescriptions</th><th align="left" valign="bottom" rowspan="1" colspan="1">Outpatient /inpatient orders</th><th align="left" valign="bottom" rowspan="1" colspan="1">Outpatient prescriptions</th><th align="left" valign="bottom" rowspan="1" colspan="1">Outpatient /inpatient orders</th><th align="left" valign="bottom" rowspan="1" colspan="1">Outpatient prescriptions</th><th align="left" valign="bottom" rowspan="1" colspan="1">Outpatient /inpatient orders</th><th align="left" valign="bottom" rowspan="1" colspan="1">Outpatient prescriptions</th><th align="left" valign="bottom" rowspan="1" colspan="1">Outpatient /inpatient orders</th><th align="left" valign="bottom" rowspan="1" colspan="1">Outpatient prescriptions</th><th align="left" valign="bottom" rowspan="1" colspan="1">Outpatient /inpatient orders</th><th align="left" valign="bottom" rowspan="1" colspan="1">Outpatient prescriptions</th><th align="left" valign="bottom" rowspan="1" colspan="1">Outpatient /inpatient orders</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Buprenorphine<xref rid="phar70024-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1.11</td><td align="left" valign="top" rowspan="1" colspan="1">0.01</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.01</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.12</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Butorphanol<xref rid="phar70024-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.03</td><td align="left" valign="top" rowspan="1" colspan="1">0.35</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.04</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.03</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Codeine<xref rid="phar70024-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">2.87</td><td align="left" valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.03</td><td align="left" valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">3.38</td><td align="left" valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.02</td><td align="left" valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.38</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1.39</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Dihydrocodeine</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fentanyl<xref rid="phar70024-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.03</td><td align="left" valign="top" rowspan="1" colspan="1">0.83</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.03</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.01</td><td align="left" valign="top" rowspan="1" colspan="1">2.24</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.60</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.98</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">1.35</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hydrocodone</td><td align="char" char="." valign="top" rowspan="1" colspan="1">3.60</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.08</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">13.73</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.16</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.65</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">4.11</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hydromorphone<xref rid="phar70024-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.13</td><td align="left" valign="top" rowspan="1" colspan="1">0.59</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.01</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.79</td><td align="left" valign="top" rowspan="1" colspan="1">1.05</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.01</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.06</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.02</td><td align="left" valign="top" rowspan="1" colspan="1">0.38</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Levorphanol</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Meperidine<xref rid="phar70024-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.02</td><td align="left" valign="top" rowspan="1" colspan="1">0.24</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.02</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.05</td><td align="left" valign="top" rowspan="1" colspan="1">0.21</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.01</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.04</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.09</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Methadone<xref rid="phar70024-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.03</td><td align="left" valign="top" rowspan="1" colspan="1">0.33</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.01</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.01</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Morphine<xref rid="phar70024-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.07</td><td align="left" valign="top" rowspan="1" colspan="1">1.16</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.09</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.17</td><td align="left" valign="top" rowspan="1" colspan="1">0.94</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.12</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.42</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.62</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nalbuphine<xref rid="phar70024-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.26</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">0.04</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.03</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Oxycodone</td><td align="char" char="." valign="top" rowspan="1" colspan="1">2.23</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.09</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">22.76</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.11</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.21</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1.44</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Oxymorphone<xref rid="phar70024-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pentazocine<xref rid="phar70024-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Remifentanil</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tapentadol</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.02</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.01</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tramadol</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.84</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.01</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1.61</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.01</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.39</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td></tr></tbody></table><table-wrap-foot id="phar70024-ntgp-0002"><fn id="phar70024-note-0002"><label>
<sup>a</sup>
</label><p>Indicates opioids with outpatient/inpatient orders.</p></fn></table-wrap-foot></table-wrap><p>The highest outpatient/inpatient orders were noted for fentanyl (2.2%) in the postpartum period, and postpartum outpatient/inpatient orders were approximately 1.0% for hydromorphone and morphine. Also, morphine (1.2%) orders were highest in the pregnant population. Whereas opioid prescription and order rates were lowest during labor/delivery, with many of the opioids being given to &lt;0.1% of the maternal population.</p><p>The total number of pediatric enrollees from 2016 to 2021 in each of the age groups included 2.8&#8201;million neonates/infants, 22&#8201;million children, and 10&#8201;million adolescents. Opioid prescriptions were highest among adolescents in the pediatric population, with hydrocodone prescribed to 4.1% of adolescents. Codeine and oxycodone were the other two opioids prescribed to &gt;1% of the adolescent population. Hydrocodone was also the most prescribed opioid among children (0.7%) and neonates/infants (0.2%).</p><p>The most outpatient/inpatient orders were noted for fentanyl and morphine across all pediatric populations, with the highest proportion of orders noted among adolescents, followed by children, and lastly the neonate/infant groups. Outpatient/inpatient fentanyl was ordered for 1.4% of the adolescents, approximately 1% of the children, and 0.6% of the neonates and infants. Whereas outpatient/inpatient morphine was ordered for 0.6% of the adolescents, 0.4% of the children, and 0.1% of the neonates/infants. Opioid prescription and order rates were lowest in the neonate/infant group.</p><p>Lastly, opioids with no or minimal (&lt;0.01%) prescription or order rates across all subpopulations included dihydrocodeine, levorphanol, oxymorphone, and remifentanil.</p></sec><sec id="phar70024-sec-0016"><label>3.4</label><title>
<styled-content style="fixed-case" toggle="no">FDA</styled-content> drug label findings</title><p>Table&#160;<xref rid="phar70024-tbl-0007" ref-type="table">7</xref> presents information on text available within the FDA opioid labels for the maternal and pediatric populations, considering the single active ingredient and its various salt forms. Four out of the 18 opioids have more than 50 drug labels, and eight out of the 18 opioids have more than 30 labels. If we consider only the main ingredient without the salt form, multiple versions of the drug labels are available for only six of the 18 opioids, including buprenorphine, fentanyl, morphine, oxycodone, sufentanil, and tramadol. The nine opioids without any FDA labels associated with them include dextropropoxyphene, dihydrocodeine, ketobemidone, meptazinol, pentazocine, phenazocine, phenoperidine, piritramide, and propoxyphene. Table&#160;<xref rid="phar70024-tbl-0008" ref-type="table">8</xref> presents findings from our analysis of FDA labels to determine the presence of data from human studies. Information based on human studies is lacking in labels for alfentanil, hydromorphone, levorphanol, and tapentadol.</p><table-wrap position="float" id="phar70024-tbl-0007" content-type="TABLE" orientation="portrait"><label>TABLE 7</label><caption><p>United States Food and Drug Administration labels for 18 opioids with any text in the maternal and pediatric sections (Single active ingredient and their salt forms).</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" valign="bottom" colspan="1">Drug name</th><th align="left" rowspan="2" valign="bottom" colspan="1">FDA labels, <italic toggle="yes">n</italic>
</th><th align="left" colspan="3" valign="bottom" rowspan="1">Maternal</th><th align="left" rowspan="2" valign="bottom" colspan="1">Pediatric</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Pregnancy</th><th align="left" valign="bottom" rowspan="1" colspan="1">Labor/delivery</th><th align="left" valign="bottom" rowspan="1" colspan="1">Lactation/nursing mothers</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Alfentanil</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Buprenorphine</td><td align="char" char="." valign="top" rowspan="1" colspan="1">33</td><td align="char" char="." valign="top" rowspan="1" colspan="1">29</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">6</td><td align="char" char="." valign="top" rowspan="1" colspan="1">29</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Butorphanol</td><td align="char" char="." valign="top" rowspan="1" colspan="1">5</td><td align="char" char="." valign="top" rowspan="1" colspan="1">3</td><td align="char" char="." valign="top" rowspan="1" colspan="1">2</td><td align="char" char="." valign="top" rowspan="1" colspan="1">3</td><td align="char" char="." valign="top" rowspan="1" colspan="1">3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Codeine</td><td align="char" char="." valign="top" rowspan="1" colspan="1">8</td><td align="char" char="." valign="top" rowspan="1" colspan="1">2</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fentanyl</td><td align="char" char="." valign="top" rowspan="1" colspan="1">33</td><td align="char" char="." valign="top" rowspan="1" colspan="1">32</td><td align="char" char="." valign="top" rowspan="1" colspan="1">18</td><td align="char" char="." valign="top" rowspan="1" colspan="1">18</td><td align="char" char="." valign="top" rowspan="1" colspan="1">32</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hydrocodone</td><td align="char" char="." valign="top" rowspan="1" colspan="1">3</td><td align="char" char="." valign="top" rowspan="1" colspan="1">3</td><td align="char" char="." valign="top" rowspan="1" colspan="1">2</td><td align="char" char="." valign="top" rowspan="1" colspan="1">2</td><td align="char" char="." valign="top" rowspan="1" colspan="1">3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hydromorphone</td><td align="char" char="." valign="top" rowspan="1" colspan="1">30</td><td align="char" char="." valign="top" rowspan="1" colspan="1">29</td><td align="char" char="." valign="top" rowspan="1" colspan="1">6</td><td align="char" char="." valign="top" rowspan="1" colspan="1">6</td><td align="char" char="." valign="top" rowspan="1" colspan="1">29</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Levorphanol</td><td align="char" char="." valign="top" rowspan="1" colspan="1">7</td><td align="char" char="." valign="top" rowspan="1" colspan="1">7</td><td align="char" char="." valign="top" rowspan="1" colspan="1">3</td><td align="char" char="." valign="top" rowspan="1" colspan="1">4</td><td align="char" char="." valign="top" rowspan="1" colspan="1">7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Meperidine</td><td align="char" char="." valign="top" rowspan="1" colspan="1">3</td><td align="char" char="." valign="top" rowspan="1" colspan="1">3</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Methadone</td><td align="char" char="." valign="top" rowspan="1" colspan="1">39</td><td align="char" char="." valign="top" rowspan="1" colspan="1">38</td><td align="char" char="." valign="top" rowspan="1" colspan="1">17</td><td align="char" char="." valign="top" rowspan="1" colspan="1">17</td><td align="char" char="." valign="top" rowspan="1" colspan="1">38</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Morphine</td><td align="char" char="." valign="top" rowspan="1" colspan="1">78</td><td align="char" char="." valign="top" rowspan="1" colspan="1">73</td><td align="char" char="." valign="top" rowspan="1" colspan="1">13</td><td align="char" char="." valign="top" rowspan="1" colspan="1">12</td><td align="char" char="." valign="top" rowspan="1" colspan="1">72</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nalbuphine</td><td align="char" char="." valign="top" rowspan="1" colspan="1">8</td><td align="char" char="." valign="top" rowspan="1" colspan="1">3</td><td align="char" char="." valign="top" rowspan="1" colspan="1">2</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Oxycodone</td><td align="char" char="." valign="top" rowspan="1" colspan="1">80</td><td align="char" char="." valign="top" rowspan="1" colspan="1">65</td><td align="char" char="." valign="top" rowspan="1" colspan="1">22</td><td align="char" char="." valign="top" rowspan="1" colspan="1">22</td><td align="char" char="." valign="top" rowspan="1" colspan="1">67</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Oxymorphone</td><td align="char" char="." valign="top" rowspan="1" colspan="1">10</td><td align="char" char="." valign="top" rowspan="1" colspan="1">6</td><td align="char" char="." valign="top" rowspan="1" colspan="1">2</td><td align="char" char="." valign="top" rowspan="1" colspan="1">2</td><td align="char" char="." valign="top" rowspan="1" colspan="1">6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Remifentanil</td><td align="char" char="." valign="top" rowspan="1" colspan="1">6</td><td align="char" char="." valign="top" rowspan="1" colspan="1">6</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sufentanil</td><td align="char" char="." valign="top" rowspan="1" colspan="1">3</td><td align="char" char="." valign="top" rowspan="1" colspan="1">3</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tapentadol</td><td align="char" char="." valign="top" rowspan="1" colspan="1">2</td><td align="char" char="." valign="top" rowspan="1" colspan="1">2</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tramadol</td><td align="char" char="." valign="top" rowspan="1" colspan="1">135</td><td align="char" char="." valign="top" rowspan="1" colspan="1">107</td><td align="char" char="." valign="top" rowspan="1" colspan="1">27</td><td align="char" char="." valign="top" rowspan="1" colspan="1">28</td><td align="char" char="." valign="top" rowspan="1" colspan="1">107</td></tr></tbody></table></table-wrap><table-wrap position="float" id="phar70024-tbl-0008" content-type="TABLE" orientation="portrait"><label>TABLE 8</label><caption><p>Availability of animal or human data for each opioid in the United States Food and Drug Administration labels.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Drug and salt form</th><th align="left" valign="bottom" rowspan="1" colspan="1">Formulation</th><th align="left" valign="bottom" rowspan="1" colspan="1">Subsection</th><th align="left" valign="bottom" rowspan="1" colspan="1">Any information (1&#8201;=&#8201;yes)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Animal data (1&#8201;=&#8201;yes)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Human data (1&#8201;=&#8201;yes)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Human PK data (1&#8201;=&#8201;yes)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Human CT data (1&#8201;=&#8201;yes)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Human PE/clinical data (1&#8201;=&#8201;yes)</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Alfentanil HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Pregnancy</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Alfentanil HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Labor/Delivery</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0004" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Alfentanil HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Lactation</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Alfentanil HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Pediatric</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Buprenorphine</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Pregnancy</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Buprenorphine</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Labor/Delivery</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Buprenorphine</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Lactation</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Buprenorphine</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Pediatric</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0005" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Butorphanol tartrate</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Pregnancy</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Butorphanol tartrate</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Labor/Delivery</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Butorphanol tartrate</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Lactation</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Butorphanol tartrate</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Pediatric</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0006" ref-type="table-fn">
<sup>c</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Codeine sulfate</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Pregnancy</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Codeine sulfate</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Labor/Delivery</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0004" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Codeine sulfate</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Lactation</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Codeine sulfate</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Pediatric</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fentanyl citrate</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Pregnancy</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0007" ref-type="table-fn">
<sup>d</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fentanyl citrate</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Labor/Delivery</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0004" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fentanyl citrate</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Lactation</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0007" ref-type="table-fn">
<sup>d</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fentanyl citrate</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Pediatric</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hydrocodone bitartrate</td><td align="left" valign="top" rowspan="1" colspan="1">Capsule</td><td align="left" valign="top" rowspan="1" colspan="1">Pregnancy</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0007" ref-type="table-fn">
<sup>d</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hydrocodone bitartrate</td><td align="left" valign="top" rowspan="1" colspan="1">Capsule</td><td align="left" valign="top" rowspan="1" colspan="1">Labor/Delivery</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0004" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hydrocodone bitartrate</td><td align="left" valign="top" rowspan="1" colspan="1">Capsule</td><td align="left" valign="top" rowspan="1" colspan="1">Lactation</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hydrocodone bitartrate</td><td align="left" valign="top" rowspan="1" colspan="1">Capsule</td><td align="left" valign="top" rowspan="1" colspan="1">Pediatric</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hydromorphone HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet/Solution</td><td align="left" valign="top" rowspan="1" colspan="1">Pregnancy</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hydromorphone HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet/Solution</td><td align="left" valign="top" rowspan="1" colspan="1">Labor/Delivery</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0004" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hydromorphone HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet/Solution</td><td align="left" valign="top" rowspan="1" colspan="1">Lactation</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hydromorphone HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet/Solution</td><td align="left" valign="top" rowspan="1" colspan="1">Pediatric</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Levorphanol tartrate</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Pregnancy</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0007" ref-type="table-fn">
<sup>d</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Levorphanol tartrate</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Labor/Delivery</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0004" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Levorphanol tartrate</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Lactation</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0004" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Levorphanol tartrate</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Pediatric</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Meperidine HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet/Solution</td><td align="left" valign="top" rowspan="1" colspan="1">Pregnancy</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0008" ref-type="table-fn">
<sup>e</sup>
</xref>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0007" ref-type="table-fn">
<sup>d</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Meperidine HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet/Solution</td><td align="left" valign="top" rowspan="1" colspan="1">Labor/Delivery</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0004" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Meperidine HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet/Solution</td><td align="left" valign="top" rowspan="1" colspan="1">Lactation</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0007" ref-type="table-fn">
<sup>d</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Meperidine HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet/Solution</td><td align="left" valign="top" rowspan="1" colspan="1">Pediatric</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Methadone HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Pregnancy</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0008" ref-type="table-fn">
<sup>e</sup>
</xref>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Methadone HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Labor/Delivery</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0004" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Methadone HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Lactation</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Methadone HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Pediatric</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0005" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Morphine sulfate</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Pregnancy</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0008" ref-type="table-fn">
<sup>e</sup>
</xref>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Morphine sulfate</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Labor/Delivery</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0004" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Morphine sulfate</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Lactation</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Morphine sulfate</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Pediatric</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nalbuphine HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Pregnancy</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nalbuphine HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Labor/Delivery</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nalbuphine HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Lactation</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0007" ref-type="table-fn">
<sup>d</sup>
</xref>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nalbuphine HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Pediatric</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0006" ref-type="table-fn">
<sup>c</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Oxycodone HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Pregnancy</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Oxycodone HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Labor/Delivery</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0004" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Oxycodone HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Lactation</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Oxycodone HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Pediatric</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Oxymorphone</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Pregnancy</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Oxymorphone</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Labor/Delivery</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Oxymorphone</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Lactation</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Oxymorphone</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Pediatric</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Remifentanil HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Pregnancy</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Remifentanil HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Labor/Delivery</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0004" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Remifentanil HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Lactation</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Remifentanil HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Pediatric</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sufentanil citrate</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Pregnancy</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sufentanil citrate</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Labor/Delivery</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sufentanil citrate</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Lactation</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sufentanil citrate</td><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">Pediatric</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tapentadol HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Pregnancy</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0007" ref-type="table-fn">
<sup>d</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tapentadol HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Labor/Delivery</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0004" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tapentadol HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Lactation</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0007" ref-type="table-fn">
<sup>d</sup>
</xref>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0007" ref-type="table-fn">
<sup>d</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tapentadol HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Tablet</td><td align="left" valign="top" rowspan="1" colspan="1">Pediatric</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tramadol HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Capsule</td><td align="left" valign="top" rowspan="1" colspan="1">Pregnancy</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1<xref rid="phar70024-note-0007" ref-type="table-fn">
<sup>d</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tramadol HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Capsule</td><td align="left" valign="top" rowspan="1" colspan="1">Labor/Delivery</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tramadol HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Capsule</td><td align="left" valign="top" rowspan="1" colspan="1">Lactation</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tramadol HCl</td><td align="left" valign="top" rowspan="1" colspan="1">Capsule</td><td align="left" valign="top" rowspan="1" colspan="1">Pediatric</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td></tr></tbody></table><table-wrap-foot id="phar70024-ntgp-0003"><fn id="phar70024-note-0003"><p>
<italic toggle="yes">Note</italic>: A value of 1 indicates that information is available in the label for the category specified in a column. Blank space denotes that no data was available for that specific opioid, subpopulation, human or animal, and/or study type(s).</p></fn><fn id="phar70024-note-0004"><label>
<sup>a</sup>
</label><p>If only any information&#8201;=&#8201;1, it indicates that some guidance based on the general opioid drug class is provided.</p></fn><fn id="phar70024-note-0005"><label>
<sup>b</sup>
</label><p>Pediatric human data are based on prenatal exposures.</p></fn><fn id="phar70024-note-0006"><label>
<sup>c</sup>
</label><p>Pediatric human data are based on exposures during labor or delivery.</p></fn><fn id="phar70024-note-0007"><label>
<sup>d</sup>
</label><p>Risk summary mentions insufficient data from studies (e.g., in pregnant women) without providing details.</p></fn><fn id="phar70024-note-0008"><label>
<sup>e</sup>
</label><p>No formal animal reproductive and developmental toxicology studies.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion" id="phar70024-sec-0017"><label>4</label><title>DISCUSSION</title><p>In this review, we provide a broad analysis of the research landscape on opioids in the maternal and pediatric populations. We have synthesized evidence from PubMed on opioid PK and PE studies as well as CT. We found that buprenorphine, fentanyl, methadone, and morphine are the most studied opioids in PK and PE/CT literature across all the maternal and pediatric subpopulations. In contrast, the MarketScan findings indicate that hydrocodone, oxycodone, and codeine are the most prescribed opioids, especially in the postpartum period and in adolescents. Although sections in the FDA labels for these three opioids contain some text, relevant data from human studies is sparse. Hydrocodone,<xref rid="phar70024-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref> oxycodone,<xref rid="phar70024-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> and codeine<xref rid="phar70024-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref> have lactation&#8208;focused PK information in the labels, and the latter two have some information for the pediatric population as well. Of the nine opioids that did not have FDA drug labels, ketobemidone<xref rid="phar70024-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref> and piritramide<xref rid="phar70024-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref> have not been approved in the United States, and dextro&#8722;/propoxyphene was withdrawn from the US market in 2010.<xref rid="phar70024-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref> Although dihydrocodeine was approved as a combination product, all current formulations are evidently discontinued by the FDA, based on their marketing status on Drugs@FDA.<xref rid="phar70024-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref> Similarly, single&#8208;ingredient formulations of pentazocine were also previously approved by the FDA but are currently discontinued. Lastly, meptazinol,<xref rid="phar70024-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref> phenazocine,<xref rid="phar70024-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref> and phenoperidine<xref rid="phar70024-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref> are considered experimental.</p><sec id="phar70024-sec-0018"><label>4.1</label><title>Three&#8208;way comparison of literature evidence, prescription/order rates, and <styled-content style="fixed-case" toggle="no">FDA</styled-content> drug labels for opioids</title><p>Findings for a three&#8208;way comparison of the literature evidence, prescription/order rates, and FDA drug labels on opioids are only available for pregnancy and labor/delivery in the maternal population and the overall pediatric population (Figure&#160;<xref rid="phar70024-fig-0005" ref-type="fig">5A&#8211;C</xref>). The joint analysis highlights differences across the three based on the prescribed/ordered opioids in these subpopulations. The findings from the evaluation of human data in the FDA labels are presented in Table&#160;<xref rid="phar70024-tbl-0008" ref-type="table">8</xref> and expanded below.</p><fig position="float" fig-type="FIGURE" id="phar70024-fig-0005" orientation="portrait"><label>FIGURE 5</label><caption><p>Knowledge gaps across pharmacoepidemiology/clinical trials and pharmacokinetics research compared to Merative MarketScan prescription/order rates and availability of the United States Food and Drug Administration (FDA) label information for pregnancy (A), labor/delivery (B), and pediatric populations (C). The dashed red line highlights the differences in highly prescribed or ordered opioids versus those commonly researched.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-9" orientation="portrait" xlink:href="PHAR-45-367-g001.jpg"/></fig><sec id="phar70024-sec-0019"><label>4.1.1</label><title>Pregnancy (Figure&#160;<xref rid="phar70024-fig-0005" ref-type="fig">5A</xref>)</title><p>Among opioids prescribed or ordered during pregnancy in MarketScan enrollees, butorphanol, hydromorphone, and pentazocine have no published PK or PE/CT evidence. Additionally, no PK studies were identified for oxymorphone, tapentadol, tramadol, or dihydrocodeine, while nalbuphine lacked PE/CT studies. Hydrocodone and oxycodone were prescribed at rates of 3.6% and 2.2%, respectively, yet lack PK studies or have fewer than five PE/CT publications each. Similarly, codeine, with a prescription rate of 2.9%, has limited literature, with fewer than five publications in both PK and PE/CT domains. Furthermore, FDA drug labels for these three opioids rely primarily on animal data, citing insufficient evidence in pregnant women for codeine and hydrocodone. To determine the need for further PK or prospective clinical studies in pregnancy, RWD studies could help validate existing findings and identify overlooked health care patterns across different states in the United States.<xref rid="phar70024-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>, <xref rid="phar70024-bib-0039" ref-type="bibr">
<sup>39</sup>
</xref>, <xref rid="phar70024-bib-0040" ref-type="bibr">
<sup>40</sup>
</xref>, <xref rid="phar70024-bib-0041" ref-type="bibr">
<sup>41</sup>
</xref>
</p><p>In contrast, methadone (0.3%) and buprenorphine (1.1%) were prescribed or ordered at lower rates among pregnant MarketScan enrollees but have substantial PK and PE/CT evidence, along with human data in FDA labels. Despite increased use through opioid agonist treatment programs, their utilization remains low in pregnancy, aligning with reported rates of 0.4% for methadone and 0.9% for buprenorphine among 2.5&#8201;million pregnant Medicaid enrollees.<xref rid="phar70024-bib-0042" ref-type="bibr">
<sup>42</sup>
</xref> Among pregnant and postpartum Medicaid enrollees with clinically documented opioid use disorder (OUD), only half received any OUD medication across 39&#8201;U.S. states between 2017 and 2018.<xref rid="phar70024-bib-0043" ref-type="bibr">
<sup>43</sup>
</xref> Multiple barriers limit access to OUD therapy in pregnancy, contributing to low utilization.<xref rid="phar70024-bib-0044" ref-type="bibr">
<sup>44</sup>
</xref> Methadone is available exclusively through specialty opioid treatment programs or inpatient settings, making initiation and maintenance difficult for pregnant individuals.<xref rid="phar70024-bib-0044" ref-type="bibr">
<sup>44</sup>
</xref>, <xref rid="phar70024-bib-0045" ref-type="bibr">
<sup>45</sup>
</xref> Although buprenorphine can be prescribed in outpatient settings, access to providers remains more challenging than access to opioid treatment programs.<xref rid="phar70024-bib-0044" ref-type="bibr">
<sup>44</sup>
</xref>, <xref rid="phar70024-bib-0046" ref-type="bibr">
<sup>46</sup>
</xref>
</p></sec><sec id="phar70024-sec-0020"><label>4.1.2</label><title>Labor or delivery (Figure&#160;<xref rid="phar70024-fig-0005" ref-type="fig">5B</xref>)</title><p>Among opioids that were prescribed or ordered during labor or delivery in MarketScan, tapentadol lacked both PK and PE/CT studies, and oxymorphone had no PE/CT evidence and only one PK study conducted during delivery.<xref rid="phar70024-bib-0047" ref-type="bibr">
<sup>47</sup>
</xref> FDA labels with human data included nalbuphine, sufentanil, and tramadol (PK data); butorphanol and nalbuphine (PE data); and butorphanol, oxymorphone, and sufentanil (CT data). Although no clinical trials for oxymorphone were identified in our primary search, a post&#8208;hoc PubMed query found three efficacy and safety studies,<xref rid="phar70024-bib-0048" ref-type="bibr">
<sup>48</sup>
</xref>, <xref rid="phar70024-bib-0049" ref-type="bibr">
<sup>49</sup>
</xref>, <xref rid="phar70024-bib-0050" ref-type="bibr">
<sup>50</sup>
</xref> with only one conducted during labor and delivery.<xref rid="phar70024-bib-0050" ref-type="bibr">
<sup>50</sup>
</xref> Although opioid prescription patterns during the postpartum period are well documented, evidence on their use during labor and delivery remains scarce.<xref rid="phar70024-bib-0051" ref-type="bibr">
<sup>51</sup>
</xref>, <xref rid="phar70024-bib-0052" ref-type="bibr">
<sup>52</sup>
</xref>, <xref rid="phar70024-bib-0053" ref-type="bibr">
<sup>53</sup>
</xref> Our claims&#8208;based analysis, using hospital and procedural codes within a 48&#8208;h window before and during delivery, captured opioid prescriptions/orders in less than 0.1% of parturients, but no directly comparable literature was found. However, extensive research exists on pain management via epidural or spinal analgesia during labor.<xref rid="phar70024-bib-0054" ref-type="bibr">
<sup>54</sup>
</xref>, <xref rid="phar70024-bib-0055" ref-type="bibr">
<sup>55</sup>
</xref> A 2008 CDC report across 27 U.S. states found that 61.0% of 1.8&#8201;million pregnant individuals with singleton vaginal deliveries received epidural or spinal anesthesia.<xref rid="phar70024-bib-0056" ref-type="bibr">
<sup>56</sup>
</xref> However, this report has limitations, such as the exclusion of cesarean deliveries, reliance on birth certificates for data collection, and convenience sampling. Additionally, opioids may or may not be used in these procedures, making their specific utilization challenging to determine.</p></sec><sec id="phar70024-sec-0021"><label>4.1.3</label><title>Pediatric (Figure&#160;<xref rid="phar70024-fig-0005" ref-type="fig">5C</xref>)</title><p>In pediatric patients, butorphanol and oxymorphone were the only prescribed or ordered opioids without PK or PE/CT literature evidence. Additionally, tapentadol had fewer than five PK studies and no PE/CT publications. Opioid prescriptions were highest among adolescents, with hydrocodone at 4.1% and oxycodone, codeine, and fentanyl reaching 1.4% each. Among these, only codeine and oxycodone had human data in FDA labels for adolescents. Although the oxymorphone FDA label includes human data for children over 12&#8201;years of age,<xref rid="phar70024-bib-0057" ref-type="bibr">
<sup>57</sup>
</xref> a web search retrieves only an abstract matching the study details in the label.<xref rid="phar70024-bib-0058" ref-type="bibr">
<sup>58</sup>
</xref> Although certain oxymorphone brands and formulations have been discontinued, findings from this study remain in the FDA label of a currently marketed formulation, raising concerns about the reliance on limited data despite the absence of a formal recommendation for its use.<xref rid="phar70024-bib-0059" ref-type="bibr">
<sup>59</sup>
</xref>
</p></sec></sec><sec id="phar70024-sec-0022"><label>4.2</label><title>Two&#8208;way comparison of literature evidence and <styled-content style="fixed-case" toggle="no">FDA</styled-content> drug labels or prescription/order rates for opioids</title><sec id="phar70024-sec-0023"><label>4.2.1</label><title>Postpartum or lactation</title><p>Opioid prescription rates were highest during the early postpartum period among MarketScan&#8208;enrolled females, with oxycodone at 22.8% and hydrocodone at 13.7%. A proportion of these individuals were likely breastfeeding, but differentiation was not possible due to the limited availability of lactation&#8208;specific codes. FDA drug labels primarily focus on lactation, with human study data available for several opioids, particularly regarding exposure through human milk. Opioids with PK information in FDA labels include buprenorphine, butorphanol, hydrocodone, methadone, morphine, nalbuphine, oxycodone, and tramadol, and codeine includes both PK and PE data. However, lactation&#8208;related literature remains sparse, with only single studies reporting PK data in breast milk for hydrocodone, oxycodone, and codeine.<xref rid="phar70024-bib-0060" ref-type="bibr">
<sup>60</sup>
</xref>, <xref rid="phar70024-bib-0061" ref-type="bibr">
<sup>61</sup>
</xref>, <xref rid="phar70024-bib-0062" ref-type="bibr">
<sup>62</sup>
</xref> Breastfeeding as a primary outcome is rarely examined in PE studies, with fewer than five publications in our analysis addressing breastfeeding&#8208;related outcomes.<xref rid="phar70024-bib-0063" ref-type="bibr">
<sup>63</sup>
</xref>, <xref rid="phar70024-bib-0064" ref-type="bibr">
<sup>64</sup>
</xref>, <xref rid="phar70024-bib-0065" ref-type="bibr">
<sup>65</sup>
</xref>, <xref rid="phar70024-bib-0066" ref-type="bibr">
<sup>66</sup>
</xref> The presence of lactation&#8208;related information in FDA labels highlights a critical need for further research in both PK and PE/CT domains.</p></sec></sec><sec id="phar70024-sec-0024"><label>4.3</label><title>Real&#8208;world evidence on opioids</title><p>Our analysis of RWD revealed significant differences in reported health outcomes. Frequently captured outcomes in RWD included NOWS, preterm births, low birth weight, opioid overdose, and health care visits. In contrast, non&#8208;RWD sources, primarily prospective or longitudinal studies with extended follow&#8208;up, commonly reported APGAR scores, neurodevelopmental or behavioral outcomes, and opioid&#8208;related dosage or side effects.</p><p>For example, neurodevelopmental outcomes were derived from studies such as Ethanol, NeuRodevelopment, Infant and Child Health (ENRICH) birth cohort, the Boston Birth Cohort, and the Maternal Life Study (MLS).<xref rid="phar70024-bib-0067" ref-type="bibr">
<sup>67</sup>
</xref>, <xref rid="phar70024-bib-0068" ref-type="bibr">
<sup>68</sup>
</xref>, <xref rid="phar70024-bib-0069" ref-type="bibr">
<sup>69</sup>
</xref>, <xref rid="phar70024-bib-0070" ref-type="bibr">
<sup>70</sup>
</xref> Conversely, NOWS was identified using International Classification of Diseases (ICD&#8208;9/10) codes from sources like the National Inpatient Sample (NIS), Medicaid claims databases, and the Kids' Inpatient Database (KID).<xref rid="phar70024-bib-0071" ref-type="bibr">
<sup>71</sup>
</xref>, <xref rid="phar70024-bib-0072" ref-type="bibr">
<sup>72</sup>
</xref>, <xref rid="phar70024-bib-0073" ref-type="bibr">
<sup>73</sup>
</xref>, <xref rid="phar70024-bib-0074" ref-type="bibr">
<sup>74</sup>
</xref>, <xref rid="phar70024-bib-0075" ref-type="bibr">
<sup>75</sup>
</xref> These examples illustrate the diversity of RWD and non&#8208;RWD sources used in outcome evaluation. Our findings demonstrate that certain outcomes are readily captured using RWD, underscoring its value for evidence generation while reducing the need for direct participant involvement in these populations.</p><p>This study has several innovations and strengths but also some limitations. It is the first to review multiple opioids in both maternal and pediatric populations, highlighting knowledge gaps in PK and PE/CT literature together with drug label and prescription/order data. The review covers diverse subpopulations and study types with certain exclusions such as PK modeling studies and reviews. We used PubMed for literature retrieval, focusing on English&#8208;language publications for accessibility and data curation within the MPRINT&#8208;KB. Our inclusion and exclusion criteria were designed to prioritize human clinical studies, which may have inadvertently excluded other relevant literature. Additionally, our prescription/orders analysis is based on a 5&#8208;year window of US claims data, which may not represent all maternal and pediatric populations across care settings, countries, or time frames. Although our primary FDA label analysis focused on the presence or absence of text in the relevant sections, manual evaluation for the existence of human data was performed for each opioid. However, this was only feasible with a single version and formulation of the FDA label available for each of the opioids. Lastly, publications after 2022 were excluded due to logistic constraints, but the KB aims to incorporate the latest research in future updates.</p><p>Our research landscape and utilization analyses reveal a disparity between commonly researched and prescribed or ordered opioids, especially in specific maternal and pediatric subpopulations, thus highlighting significant knowledge gaps. Hydrocodone, oxycodone, and codeine are the most prescribed opioids postpartum and among adolescents, yet FDA label recommendations for these drugs are based on limited human data. Real&#8208;world data will be indispensable for bridging these gaps and instrumental in evidence generation if aligned with the FDA's Framework for Real&#8208;World Evidence program.<xref rid="phar70024-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> Through MPRINT&#8208;KB, we aim to consolidate existing data on pharmacotherapies in these populations to support and accelerate future research. We anticipate MPRINT&#8208;KB to provide evidence that will aid the development of regulatory policies, including the adaptation of medication labels to more accurately reflect the efficacy and safety of opioids in the maternal and pediatric populations.</p></sec></sec><sec id="phar70024-sec-0025"><title>FUNDING INFORMATION</title><p>This study has been funded by the National Institute of Child Health and Human Development (NICHD) grants P30HD106451 and P50HD106446.</p></sec><sec sec-type="COI-statement" id="phar70024-sec-0026"><title>CONFLICT OF INTEREST STATEMENT</title><p>Sara Quinney is a member of the Pharmacotherapy editorial board. All other authors declare no conflicts of interest.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="phar70024-supitem-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>
Appendix S1
</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="PHAR-45-367-s001.pdf" position="float" orientation="portrait"/></supplementary-material></sec></body><back><sec sec-type="data-availability" id="phar70024-sec-0028"><title>DATA AVAILABILITY STATEMENT</title><p>The authors confirm that the data supporting the findings of this study are available within the article (and/or) its Appendix&#8201;<xref rid="phar70024-supitem-0001" ref-type="supplementary-material">S1</xref>. The Merative MarketScan data that support the findings of this study are available from Merative MarketScan. Restrictions apply to the availability of these data, which were used under license for this study.</p></sec><ref-list content-type="cited-references" id="phar70024-bibl-0001"><title>REFERENCES</title><ref id="phar70024-bib-0001"><label>1</label><mixed-citation publication-type="miscellaneous" id="phar70024-cit-0001"><collab collab-type="authors">Substance Abuse Mental Health Services Administration (SAMHSA)</collab>
. <article-title>Results from the 2022 National Survey on Drug Use and Health: a companion infographic Substance Abuse and Mental Health Services Administration</article-title>. <year>2024</year>. Accessed July 24, 2024. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.samhsa.gov/data/report/2022-nsduh-infographic" ext-link-type="uri">https://www.samhsa.gov/data/report/2022&#8208;nsduh&#8208;infographic</ext-link></mixed-citation></ref><ref id="phar70024-bib-0002"><label>2</label><mixed-citation publication-type="miscellaneous" id="phar70024-cit-0002"><collab collab-type="authors">Substance Abuse Mental Health Services Administration (SAMHSA)</collab>
. <article-title>2022 National Survey on Drug Use and Health: Among Females Aged 12 or Older</article-title>. <year>2024</year>. Substance Abuse and Mental Health Services Administration. Accessed July 24, 2024. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.samhsa.gov/data/sites/default/files/reports/rpt44472/2022-nsduh-pop-slides-females.pdf" ext-link-type="uri">https://www.samhsa.gov/data/sites/default/files/reports/rpt44472/2022&#8208;nsduh&#8208;pop&#8208;slides&#8208;females.pdf</ext-link></mixed-citation></ref><ref id="phar70024-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="phar70024-cit-0003"><string-name name-style="western"><surname>Duffy</surname><given-names>CR</given-names></string-name>, <string-name name-style="western"><surname>Wright</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Landau</surname><given-names>R</given-names></string-name>, et&#160;al. <article-title>Trends and outcomes associated with using long&#8208;acting opioids during delivery hospitalizations</article-title>. <source>Obstet Gynecol</source>. <year>2018</year>;<volume>132</volume>(<issue>4</issue>):<fpage>937</fpage>&#8208;<lpage>947</lpage>. doi:<pub-id pub-id-type="doi">10.1097/AOG.0000000000002861</pub-id><pub-id pub-id-type="pmid">30204694</pub-id><pub-id pub-id-type="pmcid">PMC6153065</pub-id></mixed-citation></ref><ref id="phar70024-bib-0004"><label>4</label><mixed-citation publication-type="miscellaneous" id="phar70024-cit-0004"><collab collab-type="authors">Substance Abuse Mental Health Services Administration (SAMHSA)</collab>
. <article-title>Table&#160;6.18B &#8211; Illicit drug use, marijuana use, and opioid use in past month among females aged 15 to 44, by pregnancy status, demographic, socioeconomic, and pregnancy characteristics: percentages, 2018 and 2019</article-title>. <year>2024</year>. Substance Abuse and Mental Health Services Administration. Accessed July 26, 2024. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.samhsa.gov/data/report/2019-nsduh-detailed-tables" ext-link-type="uri">https://www.samhsa.gov/data/report/2019&#8208;nsduh&#8208;detailed&#8208;tables</ext-link></mixed-citation></ref><ref id="phar70024-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="phar70024-cit-0005"><string-name name-style="western"><surname>Maeda</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Bateman</surname><given-names>BT</given-names></string-name>, <string-name name-style="western"><surname>Clancy</surname><given-names>CR</given-names></string-name>, <string-name name-style="western"><surname>Creanga</surname><given-names>AA</given-names></string-name>, <string-name name-style="western"><surname>Leffert</surname><given-names>LR</given-names></string-name>. <article-title>Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes</article-title>. <source>Anesthesiology</source>. <year>2014</year>;<volume>121</volume>(<issue>6</issue>):<fpage>1158</fpage>&#8208;<lpage>1165</lpage>. doi:<pub-id pub-id-type="doi">10.1097/ALN.0000000000000472</pub-id><pub-id pub-id-type="pmid">25405293</pub-id></mixed-citation></ref><ref id="phar70024-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="phar70024-cit-0006"><string-name name-style="western"><surname>Ko</surname><given-names>JY</given-names></string-name>, <string-name name-style="western"><surname>D'Angelo</surname><given-names>DV</given-names></string-name>, <string-name name-style="western"><surname>Haight</surname><given-names>SC</given-names></string-name>, et&#160;al. <article-title>Vital signs: prescription opioid pain reliever use during pregnancy &#8208; 34 U.S. jurisdictions, 2019</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>2020</year>;<volume>69</volume>(<issue>28</issue>):<fpage>897</fpage>&#8208;<lpage>903</lpage>. doi:<pub-id pub-id-type="doi">10.15585/mmwr.mm6928a1</pub-id><pub-id pub-id-type="pmid">32673301</pub-id><pub-id pub-id-type="pmcid">PMC7366850</pub-id></mixed-citation></ref><ref id="phar70024-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="phar70024-cit-0007"><string-name name-style="western"><surname>Ryan</surname><given-names>KS</given-names></string-name>, <string-name name-style="western"><surname>Prewitt</surname><given-names>KC</given-names></string-name>, <string-name name-style="western"><surname>Hayer</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Hedges</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Benson</surname><given-names>AE</given-names></string-name>, <string-name name-style="western"><surname>Lo</surname><given-names>JO</given-names></string-name>. <article-title>Opioid use in pregnancy: a review</article-title>. <source>Obstet Gynecol Surv</source>. <year>2023</year>;<volume>78</volume>(<issue>1</issue>):<fpage>35</fpage>&#8208;<lpage>49</lpage>. doi:<pub-id pub-id-type="doi">10.1097/OGX.0000000000001094</pub-id><pub-id pub-id-type="pmid">36607200</pub-id></mixed-citation></ref><ref id="phar70024-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="phar70024-cit-0008"><string-name name-style="western"><surname>Zipursky</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Juurlink</surname><given-names>DN</given-names></string-name>. <article-title>Opioid use in pregnancy: an emerging health crisis</article-title>. <source>Obstet Med</source>. <year>2021</year>;<volume>14</volume>(<issue>4</issue>):<fpage>211</fpage>&#8208;<lpage>219</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1753495X20971163</pub-id><pub-id pub-id-type="pmid">34880933</pub-id><pub-id pub-id-type="pmcid">PMC8646213</pub-id></mixed-citation></ref><ref id="phar70024-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="phar70024-cit-0009"><string-name name-style="western"><surname>Arter</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Tyler</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>McAllister</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Kiel</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Guler</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Cameron</surname><given-names>HM</given-names></string-name>. <article-title>Longitudinal outcomes of children exposed to opioids in&#8208;utero: a systematic review</article-title>. <source>J Nurs Scholarsh</source>. <year>2021</year>;<volume>53</volume>(<issue>1</issue>):<fpage>55</fpage>&#8208;<lpage>64</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jnu.12609</pub-id><pub-id pub-id-type="pmid">33225521</pub-id></mixed-citation></ref><ref id="phar70024-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="phar70024-cit-0010"><string-name name-style="western"><surname>Patrick</surname><given-names>SW</given-names></string-name>, <string-name name-style="western"><surname>Schumacher</surname><given-names>RE</given-names></string-name>, <string-name name-style="western"><surname>Benneyworth</surname><given-names>BD</given-names></string-name>, <string-name name-style="western"><surname>Krans</surname><given-names>EE</given-names></string-name>, <string-name name-style="western"><surname>McAllister</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Davis</surname><given-names>MM</given-names></string-name>. <article-title>Neonatal abstinence syndrome and associated health care expenditures: United States, 2000&#8211;2009</article-title>. <source>JAMA</source>. <year>2012</year>;<volume>307</volume>(<issue>18</issue>):<fpage>1934</fpage>&#8208;<lpage>1940</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2012.3951</pub-id><pub-id pub-id-type="pmid">22546608</pub-id></mixed-citation></ref><ref id="phar70024-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="phar70024-cit-0011"><string-name name-style="western"><surname>Esposito</surname><given-names>DB</given-names></string-name>, <string-name name-style="western"><surname>Huybrechts</surname><given-names>KF</given-names></string-name>, <string-name name-style="western"><surname>Werler</surname><given-names>MM</given-names></string-name>, et&#160;al. <article-title>Characteristics of prescription opioid analgesics in pregnancy and risk of neonatal opioid withdrawal syndrome in newborns</article-title>. <source>JAMA Netw Open</source>. <year>2022</year>;<volume>5</volume>(<issue>8</issue>):<elocation-id>e2228588</elocation-id>. doi:<pub-id pub-id-type="doi">10.1001/jamanetworkopen.2022.28588</pub-id><pub-id pub-id-type="pmid">36001312</pub-id><pub-id pub-id-type="pmcid">PMC9403776</pub-id></mixed-citation></ref><ref id="phar70024-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="phar70024-cit-0012"><string-name name-style="western"><surname>Desai</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Huybrechts</surname><given-names>KF</given-names></string-name>, <string-name name-style="western"><surname>Hernandez&#8208;Diaz</surname><given-names>S</given-names></string-name>, et&#160;al. <article-title>Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study</article-title>. <source>BMJ</source>. <year>2015</year>;<volume>350</volume>:<elocation-id>h2102</elocation-id>. doi:<pub-id pub-id-type="doi">10.1136/bmj.h2102</pub-id><pub-id pub-id-type="pmid">25975601</pub-id><pub-id pub-id-type="pmcid">PMC4431352</pub-id></mixed-citation></ref><ref id="phar70024-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="phar70024-cit-0013"><string-name name-style="western"><surname>Giovannini</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Bonasoni</surname><given-names>MP</given-names></string-name>, <string-name name-style="western"><surname>Pascali</surname><given-names>JP</given-names></string-name>, et&#160;al. <article-title>Fetal and infant effects of maternal opioid use during pregnancy: a literature review including clinical, toxicological, pharmacogenomic, and epigenetic aspects for forensic evaluation</article-title>. <source>Children (Basel)</source>. <year>2024</year>;<volume>11</volume>(<issue>3</issue>):<elocation-id>278</elocation-id>. doi:<pub-id pub-id-type="doi">10.3390/children11030278</pub-id><pub-id pub-id-type="pmid">38539313</pub-id><pub-id pub-id-type="pmcid">PMC10969201</pub-id></mixed-citation></ref><ref id="phar70024-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="phar70024-cit-0014"><string-name name-style="western"><surname>Groenewald</surname><given-names>CB</given-names></string-name>. <article-title>Opioid&#8208;prescribing patterns for pediatric patients in the United States</article-title>. <source>Clin J Pain</source>. <year>2019</year>;<volume>35</volume>(<issue>6</issue>):<fpage>515</fpage>&#8208;<lpage>520</lpage>. doi:<pub-id pub-id-type="doi">10.1097/AJP.0000000000000707</pub-id><pub-id pub-id-type="pmid">30985396</pub-id><pub-id pub-id-type="pmcid">PMC6782052</pub-id></mixed-citation></ref><ref id="phar70024-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="phar70024-cit-0015"><string-name name-style="western"><surname>Chua</surname><given-names>KP</given-names></string-name>, <string-name name-style="western"><surname>Brummett</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Conti</surname><given-names>RM</given-names></string-name>, <string-name name-style="western"><surname>Bohnert</surname><given-names>AS</given-names></string-name>. <article-title>Opioid prescribing to US children and young adults in 2019</article-title>. <source>Pediatrics</source>. <year>2021</year>;<volume>148</volume>(<issue>3</issue>):<elocation-id>e2021051539</elocation-id>. doi:<pub-id pub-id-type="doi">10.1542/peds.2021-051539</pub-id><pub-id pub-id-type="pmid">34400571</pub-id><pub-id pub-id-type="pmcid">PMC8778996</pub-id></mixed-citation></ref><ref id="phar70024-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="phar70024-cit-0016"><string-name name-style="western"><surname>McKiever</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Frey</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Costantine</surname><given-names>MM</given-names></string-name>. <article-title>Challenges in conducting clinical research studies in pregnant women</article-title>. <source>J Pharmacokinet Pharmacodyn</source>. <year>2020</year>;<volume>47</volume>(<issue>4</issue>):<fpage>287</fpage>&#8208;<lpage>293</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10928-020-09687-z</pub-id><pub-id pub-id-type="pmid">32306165</pub-id><pub-id pub-id-type="pmcid">PMC8237366</pub-id></mixed-citation></ref><ref id="phar70024-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="phar70024-cit-0017"><string-name name-style="western"><surname>Hwang</surname><given-names>TJ</given-names></string-name>, <string-name name-style="western"><surname>Orenstein</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Kesselheim</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Bourgeois</surname><given-names>FT</given-names></string-name>. <article-title>Completion rate and reporting of mandatory pediatric postmarketing studies under the US pediatric research equity act</article-title>. <source>JAMA Pediatr</source>. <year>2019</year>;<volume>173</volume>(<issue>1</issue>):<fpage>68</fpage>&#8208;<lpage>74</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jamapediatrics.2018.3416</pub-id><pub-id pub-id-type="pmid">30452498</pub-id><pub-id pub-id-type="pmcid">PMC6583440</pub-id></mixed-citation></ref><ref id="phar70024-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="phar70024-cit-0018"><string-name name-style="western"><surname>Kazma</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>van den Anker</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Allegaert</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Dallmann</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Ahmadzia</surname><given-names>HK</given-names></string-name>. <article-title>Anatomical and physiological alterations of pregnancy</article-title>. <source>J Pharmacokinet Pharmacodyn</source>. <year>2020</year>;<volume>47</volume>(<issue>4</issue>):<fpage>271</fpage>&#8208;<lpage>285</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10928-020-09677-1</pub-id><pub-id pub-id-type="pmid">32026239</pub-id><pub-id pub-id-type="pmcid">PMC7416543</pub-id></mixed-citation></ref><ref id="phar70024-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="phar70024-cit-0019"><string-name name-style="western"><surname>Anderson</surname><given-names>D</given-names></string-name>. <article-title>A review of systemic opioids commonly used for labor pain relief</article-title>. <source>J Midwifery Womens Health</source>. <year>2011</year>;<volume>56</volume>(<issue>3</issue>):<fpage>222</fpage>&#8208;<lpage>239</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1542-2011.2011.00061.x</pub-id><pub-id pub-id-type="pmid">21535371</pub-id></mixed-citation></ref><ref id="phar70024-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="phar70024-cit-0020"><string-name name-style="western"><surname>Thigpen</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Odle</surname><given-names>BL</given-names></string-name>, <string-name name-style="western"><surname>Harirforoosh</surname><given-names>S</given-names></string-name>. <article-title>Opioids: a review of pharmacokinetics and pharmacodynamics in neonates, infants, and children</article-title>. <source>Eur J Drug Metab Pharmacokinet</source>. <year>2019</year>;<volume>44</volume>(<issue>5</issue>):<fpage>591</fpage>&#8208;<lpage>609</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s13318-019-00552-0</pub-id><pub-id pub-id-type="pmid">31006834</pub-id></mixed-citation></ref><ref id="phar70024-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="phar70024-cit-0021"><string-name name-style="western"><surname>Bateman</surname><given-names>BT</given-names></string-name>, <string-name name-style="western"><surname>Hernandez&#8208;Diaz</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Rathmell</surname><given-names>JP</given-names></string-name>, et&#160;al. <article-title>Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States</article-title>. <source>Anesthesiology</source>. <year>2014</year>;<volume>120</volume>(<issue>5</issue>):<fpage>1216</fpage>&#8208;<lpage>1224</lpage>. doi:<pub-id pub-id-type="doi">10.1097/ALN.0000000000000172</pub-id><pub-id pub-id-type="pmid">24525628</pub-id><pub-id pub-id-type="pmcid">PMC3999216</pub-id></mixed-citation></ref><ref id="phar70024-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="phar70024-cit-0022"><string-name name-style="western"><surname>Zhu</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Vora</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Menon</surname><given-names>S</given-names></string-name>, et&#160;al. <article-title>Clinical pharmacology applications of real&#8208;world data and real&#8208;world evidence in drug development and approval &#8211; an industry perspective</article-title>. <source>Clin Pharmacol Ther</source>. <year>2023</year>;<volume>114</volume>(<issue>4</issue>):<fpage>751</fpage>&#8208;<lpage>767</lpage>. doi:<pub-id pub-id-type="doi">10.1002/cpt.2988</pub-id><pub-id pub-id-type="pmid">37393555</pub-id></mixed-citation></ref><ref id="phar70024-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="phar70024-cit-0023"><string-name name-style="western"><surname>Quinney</surname><given-names>SK</given-names></string-name>, <string-name name-style="western"><surname>Bies</surname><given-names>RR</given-names></string-name>, <string-name name-style="western"><surname>Grannis</surname><given-names>SJ</given-names></string-name>, et&#160;al. <article-title>The MPRINT hub data, model, knowledge and research coordination center: bridging the gap in maternal&#8208;pediatric therapeutics research through data integration and pharmacometrics</article-title>. <source>Pharmacotherapy</source>. <year>2023</year>;<volume>43</volume>(<issue>5</issue>):<fpage>391</fpage>&#8208;<lpage>402</lpage>. doi:<pub-id pub-id-type="doi">10.1002/phar.2765</pub-id><pub-id pub-id-type="pmid">36625779</pub-id><pub-id pub-id-type="pmcid">PMC10192201</pub-id></mixed-citation></ref><ref id="phar70024-bib-0024"><label>24</label><mixed-citation publication-type="miscellaneous" id="phar70024-cit-0024"><collab collab-type="authors">Merative</collab>
. <article-title>Merative MarketScan Research Databases</article-title>. <year>2024</year>. Accessed July 01, 2024. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://assets.merative.com/m/4e9e9971589b0f0f/original/MarketScan_Merative-MarketScan-Research-Databases_Solution-Brief.PDF" ext-link-type="uri">https://assets.merative.com/m/4e9e9971589b0f0f/original/MarketScan_Merative&#8208;MarketScan&#8208;Research&#8208;Databases_Solution&#8208;Brief.PDF</ext-link></mixed-citation></ref><ref id="phar70024-bib-0025"><label>25</label><mixed-citation publication-type="miscellaneous" id="phar70024-cit-0025"><collab collab-type="authors">WHO Collaborating Centre for Drug Statistics Methodology</collab>
. <article-title>Anatomical Therapeutic Chemical (ATC) classification system. International language for drug utilization research</article-title>. <year>2024</year> Accessed October 04, 2024. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://atcddd.fhi.no/atc/structure_and_principles/" ext-link-type="uri">https://atcddd.fhi.no/atc/structure_and_principles/</ext-link></mixed-citation></ref><ref id="phar70024-bib-0026"><label>26</label><mixed-citation publication-type="miscellaneous" id="phar70024-cit-0026"><collab collab-type="authors">National Institute of Child Health and Human Development and National Cancer Institute's Enterprise Vocabulary Services</collab>
. <article-title>NICHD Pediatric Terminology Files</article-title>. <year>2024</year>. NICHD. Accessed November 30, 2024. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://evs.nci.nih.gov/ftp1/Pediatric_Terminologies/NICHD/About.html" ext-link-type="uri">https://evs.nci.nih.gov/ftp1/Pediatric_Terminologies/NICHD/About.html</ext-link></mixed-citation></ref><ref id="phar70024-bib-0027"><label>27</label><mixed-citation publication-type="miscellaneous" id="phar70024-cit-0027"><collab collab-type="authors">U.S. Food and Drug Administration (FDA)</collab>
. <article-title>Framework for FDA's Real&#8208;World Evidence Program</article-title>. <year>2024</year> U.S. Department of Health and Human Services. Accessed November 14, 2024. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.fda.gov/media/120060/download" ext-link-type="uri">https://www.fda.gov/media/120060/download</ext-link></mixed-citation></ref><ref id="phar70024-bib-0028"><label>28</label><mixed-citation publication-type="miscellaneous" id="phar70024-cit-0028"><collab collab-type="authors">U.S. Food and Drug Administration (FDA)</collab>
. <article-title>FDA drug labeling files</article-title>. <year>2023</year> U.S. Department of Health and Human Services. Accessed October 30, 2023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://open.fda.gov/apis/drug/label/download/" ext-link-type="uri">https://open.fda.gov/apis/drug/label/download/</ext-link></mixed-citation></ref><ref id="phar70024-bib-0029"><label>29</label><mixed-citation publication-type="miscellaneous" id="phar70024-cit-0029"><collab collab-type="authors">U.S. Food and Drug Administration (FDA)</collab>
. <article-title>Hydrocodone bitartarate FDA drug label</article-title>. <year>2024</year>. Updated 12/2023. Accessed October 28, 2024. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206627s015lbl.pdf" ext-link-type="uri">https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206627s015lbl.pdf</ext-link></mixed-citation></ref><ref id="phar70024-bib-0030"><label>30</label><mixed-citation publication-type="miscellaneous" id="phar70024-cit-0030"><collab collab-type="authors">U.S. Food and Drug Administration (FDA)</collab>
. <article-title>Oxycodone hydrochloride FDA drug label</article-title>. <year>2024</year>. Updated 12/2023. Accessed October 28, 2024. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022272s048lbl.pdf" ext-link-type="uri">https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022272s048lbl.pdf</ext-link></mixed-citation></ref><ref id="phar70024-bib-0031"><label>31</label><mixed-citation publication-type="miscellaneous" id="phar70024-cit-0031"><collab collab-type="authors">U.S. Food and Drug Administration (FDA)</collab>
. <article-title>Codeine sulfate FDA drug label</article-title>. <year>2024</year>. Updated 12/2023. Accessed October 28, 2024. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022402s015lbl.pdf" ext-link-type="uri">https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022402s015lbl.pdf</ext-link></mixed-citation></ref><ref id="phar70024-bib-0032"><label>32</label><mixed-citation publication-type="miscellaneous" id="phar70024-cit-0032"><collab collab-type="authors">Drugbank</collab>
. <article-title>Ketobemidone (DB06738)</article-title>. <year>2024</year>. Updated 12/03/2024. Accessed October 24, 2024, 2024. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://go.drugbank.com/drugs/DB06738" ext-link-type="uri">https://go.drugbank.com/drugs/DB06738</ext-link></mixed-citation></ref><ref id="phar70024-bib-0033"><label>33</label><mixed-citation publication-type="miscellaneous" id="phar70024-cit-0033"><collab collab-type="authors">Drugbank</collab>
. <article-title>Piritramide (DB12492)</article-title>. <year>2024</year>. Updated 07/03/2021. Accessed October 25, 2024. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://go.drugbank.com/drugs/DB12492" ext-link-type="uri">https://go.drugbank.com/drugs/DB12492</ext-link></mixed-citation></ref><ref id="phar70024-bib-0034"><label>34</label><mixed-citation publication-type="miscellaneous" id="phar70024-cit-0034"><collab collab-type="authors">U.S. Food and Drug Administration (FDA)</collab>
. <article-title>Timeline of selected FDA activities and significant events addressing substance use and overdose prevention</article-title>. <year>2024</year>. U.S. Department of Health and Human Services. Accessed November 22, 2024. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.fda.gov/drugs/food-and-drug-administration-overdose-prevention-framework/timeline-selected-fda-activities-and-significant-events-addressing-substance-use-and-overdose" ext-link-type="uri">https://www.fda.gov/drugs/food&#8208;and&#8208;drug&#8208;administration&#8208;overdose&#8208;prevention&#8208;framework/timeline&#8208;selected&#8208;fda&#8208;activities&#8208;and&#8208;significant&#8208;events&#8208;addressing&#8208;substance&#8208;use&#8208;and&#8208;overdose</ext-link></mixed-citation></ref><ref id="phar70024-bib-0035"><label>35</label><mixed-citation publication-type="miscellaneous" id="phar70024-cit-0035"><collab collab-type="authors">U.S. Food and Drug Administration (FDA)</collab>
. <article-title>Drugs@FDA: FDA&#8208;Approved Drugs</article-title>. <year>2024</year>. Accessed November 24, 2024. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm" ext-link-type="uri">https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm</ext-link></mixed-citation></ref><ref id="phar70024-bib-0036"><label>36</label><mixed-citation publication-type="miscellaneous" id="phar70024-cit-0036"><collab collab-type="authors">Drugbank</collab>
. <article-title>Meptazinol (DB13478)</article-title>. <year>2024</year>. Updated 08/27/2024. Accessed October 25, 2024. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://go.drugbank.com/drugs/DB13478" ext-link-type="uri">https://go.drugbank.com/drugs/DB13478</ext-link></mixed-citation></ref><ref id="phar70024-bib-0037"><label>37</label><mixed-citation publication-type="miscellaneous" id="phar70024-cit-0037"><collab collab-type="authors">Drugbank</collab>
. <article-title>Phenazocine (DB13606)</article-title>. <year>2024</year>. Updated 06/12/2020. Accessed October 25, 2024. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://go.drugbank.com/drugs/DB13606" ext-link-type="uri">https://go.drugbank.com/drugs/DB13606</ext-link></mixed-citation></ref><ref id="phar70024-bib-0038"><label>38</label><mixed-citation publication-type="miscellaneous" id="phar70024-cit-0038"><collab collab-type="authors">Drugbank</collab>
. <article-title>Phenoperidine (DB13605)</article-title>. <year>2024</year>. Updated 02/21/2021. Accessed October 25, 2024. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://go.drugbank.com/drugs/DB13605" ext-link-type="uri">https://go.drugbank.com/drugs/DB13605</ext-link></mixed-citation></ref><ref id="phar70024-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="phar70024-cit-0039"><string-name name-style="western"><surname>Jarlenski</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>JY</given-names></string-name>, <string-name name-style="western"><surname>Ahrens</surname><given-names>KA</given-names></string-name>, et&#160;al. <article-title>Healthcare patterns of pregnant women and children affected by OUD in 9 state Medicaid populations</article-title>. <source>J Addict Med</source>. <year>2021</year>;<volume>15</volume>(<issue>5</issue>):<fpage>406</fpage>&#8208;<lpage>413</lpage>. doi:<pub-id pub-id-type="doi">10.1097/ADM.0000000000000780</pub-id><pub-id pub-id-type="pmid">33560699</pub-id><pub-id pub-id-type="pmcid">PMC8339176</pub-id></mixed-citation></ref><ref id="phar70024-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="phar70024-cit-0040"><string-name name-style="western"><surname>Nechuta</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Mukhopadhyay</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Golladay</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Rainey</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Krishnaswami</surname><given-names>S</given-names></string-name>. <article-title>Trends, patterns, and maternal characteristics of opioid prescribing during pregnancy in a large population&#8208;based cohort study</article-title>. <source>Drug Alcohol Depend</source>. <year>2022</year>;<volume>233</volume>:<elocation-id>109331</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.drugalcdep.2022.109331</pub-id><pub-id pub-id-type="pmid">35149439</pub-id><pub-id pub-id-type="pmcid">PMC10838571</pub-id></mixed-citation></ref><ref id="phar70024-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="phar70024-cit-0041"><string-name name-style="western"><surname>Qato</surname><given-names>DM</given-names></string-name>, <string-name name-style="western"><surname>Gandhi</surname><given-names>AB</given-names></string-name>. <article-title>Opioid and benzodiazepine dispensing and co&#8208;dispensing patterns among commercially insured pregnant women in the United States, 2007&#8211;2015</article-title>. <source>BMC Pregnancy Childbirth</source>. <year>2021</year>;<volume>21</volume>(<issue>1</issue>):<fpage>350</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12884-021-03787-5</pub-id><pub-id pub-id-type="pmid">33941106</pub-id><pub-id pub-id-type="pmcid">PMC8091773</pub-id></mixed-citation></ref><ref id="phar70024-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="phar70024-cit-0042"><string-name name-style="western"><surname>Suarez</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Huybrechts</surname><given-names>KF</given-names></string-name>, <string-name name-style="western"><surname>Straub</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>Buprenorphine versus methadone for opioid use disorder in pregnancy</article-title>. <source>N Engl J Med</source>. <year>2022</year>;<volume>387</volume>(<issue>22</issue>):<fpage>2033</fpage>&#8208;<lpage>2044</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMoa2203318</pub-id><pub-id pub-id-type="pmid">36449419</pub-id><pub-id pub-id-type="pmcid">PMC9873239</pub-id></mixed-citation></ref><ref id="phar70024-bib-0043"><label>43</label><mixed-citation publication-type="miscellaneous" id="phar70024-cit-0043"><string-name name-style="western"><surname>Roberts</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Frederiksen</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Saunders</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Salganicoff</surname><given-names>A</given-names></string-name>. <article-title>Opioid use disorder and treatment among pregnant and postpartum medicaid enrollees</article-title>. <year>2025</year>. KFF. Accessed 02/10/2025. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.kff.org/medicaid/issue-brief/opioid-use-disorder-and-treatment-among-pregnant-and-postpartum-medicaid-enrollees/" ext-link-type="uri">https://www.kff.org/medicaid/issue&#8208;brief/opioid&#8208;use&#8208;disorder&#8208;and&#8208;treatment&#8208;among&#8208;pregnant&#8208;and&#8208;postpartum&#8208;medicaid&#8208;enrollees/</ext-link></mixed-citation></ref><ref id="phar70024-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="phar70024-cit-0044"><string-name name-style="western"><surname>Bedrick</surname><given-names>BS</given-names></string-name>, <string-name name-style="western"><surname>O'Donnell</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Marx</surname><given-names>CM</given-names></string-name>, et&#160;al. <article-title>Barriers to accessing opioid agonist therapy in pregnancy</article-title>. <source>Am J Obstet Gynecol MFM</source>. <year>2020</year>;<volume>2</volume>(<issue>4</issue>):<elocation-id>100225</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.ajogmf.2020.100225</pub-id><pub-id pub-id-type="pmid">33345932</pub-id></mixed-citation></ref><ref id="phar70024-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="phar70024-cit-0045"><article-title>Committee Opinion No. 711: Opioid use and opioid use disorder in pregnancy</article-title>. <source>Obstet Gynecol</source>. <year>2017</year>;<volume>130</volume>:<fpage>e81</fpage>&#8208;<lpage>e94</lpage>. doi:<pub-id pub-id-type="doi">10.1097/AOG.0000000000002235</pub-id><pub-id pub-id-type="pmid">28742676</pub-id></mixed-citation></ref><ref id="phar70024-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="phar70024-cit-0046"><string-name name-style="western"><surname>Patrick</surname><given-names>SW</given-names></string-name>, <string-name name-style="western"><surname>Buntin</surname><given-names>MB</given-names></string-name>, <string-name name-style="western"><surname>Martin</surname><given-names>PR</given-names></string-name>, et&#160;al. <article-title>Barriers to accessing treatment for pregnant women with opioid use disorder in Appalachian states</article-title>. <source>Subst Abus</source>. <year>2019</year>;<volume>40</volume>(<issue>3</issue>):<fpage>356</fpage>&#8208;<lpage>362</lpage>. doi:<pub-id pub-id-type="doi">10.1080/08897077.2018.1488336</pub-id><pub-id pub-id-type="pmid">29949454</pub-id><pub-id pub-id-type="pmcid">PMC9069995</pub-id></mixed-citation></ref><ref id="phar70024-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="phar70024-cit-0047"><string-name name-style="western"><surname>Boswell</surname><given-names>MV</given-names></string-name>, <string-name name-style="western"><surname>Stauble</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Loyd</surname><given-names>GE</given-names></string-name>, et&#160;al. <article-title>The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone</article-title>. <source>Pain Physician</source>. <year>2013</year>;<volume>16</volume>(<issue>3</issue>):<fpage>E227</fpage>&#8208;<lpage>E235</lpage>.<pub-id pub-id-type="pmid">23703421</pub-id></mixed-citation></ref><ref id="phar70024-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="phar70024-cit-0048"><string-name name-style="western"><surname>Sinatra</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Chung</surname><given-names>KS</given-names></string-name>, <string-name name-style="western"><surname>Silverman</surname><given-names>DG</given-names></string-name>, et&#160;al. <article-title>An evaluation of morphine and oxymorphone administered via patient&#8208;controlled analgesia (PCA) or PCA plus basal infusion in postcesarean&#8208;delivery patients</article-title>. <source>Anesthesiology</source>. <year>1989</year>;<volume>71</volume>(<issue>4</issue>):<fpage>502</fpage>&#8208;<lpage>507</lpage>. doi:<pub-id pub-id-type="doi">10.1097/00000542-198910000-00005</pub-id><pub-id pub-id-type="pmid">2478049</pub-id></mixed-citation></ref><ref id="phar70024-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="phar70024-cit-0049"><string-name name-style="western"><surname>Sinatra</surname><given-names>RS</given-names></string-name>, <string-name name-style="western"><surname>Lodge</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Sibert</surname><given-names>K</given-names></string-name>, et&#160;al. <article-title>A comparison of morphine, meperidine, and oxymorphone as utilized in patient&#8208;controlled analgesia following cesarean delivery</article-title>. <source>Anesthesiology</source>. <year>1989</year>;<volume>70</volume>(<issue>4</issue>):<fpage>585</fpage>&#8208;<lpage>590</lpage>. doi:<pub-id pub-id-type="doi">10.1097/00000542-198904000-00005</pub-id><pub-id pub-id-type="pmid">2467588</pub-id></mixed-citation></ref><ref id="phar70024-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="phar70024-cit-0050"><string-name name-style="western"><surname>Celleno</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Capogna</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Sebastiani</surname><given-names>M</given-names></string-name>, et&#160;al. <article-title>Epidural analgesia during and after cesarean delivery. Comparison of five opioids</article-title>. <source>Reg Anesth Pain Med</source>. <year>1991</year>;<volume>16</volume>(<issue>2</issue>):<fpage>79</fpage>&#8208;<lpage>83</lpage>.<pub-id pub-id-type="pmid">1675119</pub-id></mixed-citation></ref><ref id="phar70024-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="phar70024-cit-0051"><string-name name-style="western"><surname>Peahl</surname><given-names>AF</given-names></string-name>, <string-name name-style="western"><surname>Dalton</surname><given-names>VK</given-names></string-name>, <string-name name-style="western"><surname>Montgomery</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Lai</surname><given-names>YL</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>HM</given-names></string-name>, <string-name name-style="western"><surname>Waljee</surname><given-names>JF</given-names></string-name>. <article-title>Rates of new persistent opioid use after vaginal or cesarean birth among US women</article-title>. <source>JAMA Netw Open</source>. <year>2019</year>;<volume>2</volume>(<issue>7</issue>):<elocation-id>e197863</elocation-id>. doi:<pub-id pub-id-type="doi">10.1001/jamanetworkopen.2019.7863</pub-id><pub-id pub-id-type="pmid">31348508</pub-id><pub-id pub-id-type="pmcid">PMC6661716</pub-id></mixed-citation></ref><ref id="phar70024-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="phar70024-cit-0052"><string-name name-style="western"><surname>Osmundson</surname><given-names>SS</given-names></string-name>, <string-name name-style="western"><surname>Min</surname><given-names>JY</given-names></string-name>, <string-name name-style="western"><surname>Grijalva</surname><given-names>CG</given-names></string-name>. <article-title>Opioid prescribing after childbirth: overprescribing and chronic use</article-title>. <source>Curr Opin Obstet Gynecol</source>. <year>2019</year>;<volume>31</volume>(<issue>2</issue>):<fpage>83</fpage>&#8208;<lpage>89</lpage>. doi:<pub-id pub-id-type="doi">10.1097/GCO.0000000000000527</pub-id><pub-id pub-id-type="pmid">30789842</pub-id><pub-id pub-id-type="pmcid">PMC7195695</pub-id></mixed-citation></ref><ref id="phar70024-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="phar70024-cit-0053"><string-name name-style="western"><surname>Osmundson</surname><given-names>SS</given-names></string-name>, <string-name name-style="western"><surname>Wiese</surname><given-names>AD</given-names></string-name>, <string-name name-style="western"><surname>Min</surname><given-names>JY</given-names></string-name>, et&#160;al. <article-title>Delivery type, opioid prescribing, and the risk of persistent opioid use after delivery</article-title>. <source>Am J Obstet Gynecol</source>. <year>2019</year>;<volume>220</volume>(<issue>4</issue>):<fpage>405</fpage>&#8208;<lpage>407</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ajog.2018.10.026</pub-id><pub-id pub-id-type="pmid">30955527</pub-id><pub-id pub-id-type="pmcid">PMC6546169</pub-id></mixed-citation></ref><ref id="phar70024-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="phar70024-cit-0054"><string-name name-style="western"><surname>Anim&#8208;Somuah</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Smyth</surname><given-names>RM</given-names></string-name>, <string-name name-style="western"><surname>Cyna</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Cuthbert</surname><given-names>A</given-names></string-name>. <article-title>Epidural versus non&#8208;epidural or no analgesia for pain management in labour</article-title>. <source>Cochrane Database Syst Rev</source>. <year>2018</year>;<volume>5</volume>(<issue>5</issue>):<elocation-id>CD000331</elocation-id>. doi:<pub-id pub-id-type="doi">10.1002/14651858.CD000331.pub4</pub-id><pub-id pub-id-type="pmid">29781504</pub-id><pub-id pub-id-type="pmcid">PMC6494646</pub-id></mixed-citation></ref><ref id="phar70024-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="phar70024-cit-0055"><string-name name-style="western"><surname>Simmons</surname><given-names>SW</given-names></string-name>, <string-name name-style="western"><surname>Taghizadeh</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Dennis</surname><given-names>AT</given-names></string-name>, <string-name name-style="western"><surname>Hughes</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Cyna</surname><given-names>AM</given-names></string-name>. <article-title>Combined spinal&#8208;epidural versus epidural analgesia in labour</article-title>. <source>Cochrane Database Syst Rev</source>. <year>2012</year>;<volume>10</volume>(<issue>10</issue>):<elocation-id>CD003401</elocation-id>. doi:<pub-id pub-id-type="doi">10.1002/14651858.CD003401.pub3</pub-id><pub-id pub-id-type="pmid">23076897</pub-id><pub-id pub-id-type="pmcid">PMC7154384</pub-id></mixed-citation></ref><ref id="phar70024-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="phar70024-cit-0056"><string-name name-style="western"><surname>Osterman</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Martin</surname><given-names>JA</given-names></string-name>. <article-title>Epidural and spinal anesthesia use during labor: 27&#8208;state reporting area, 2008</article-title>. <source>Natl Vital Stat Rep</source>. <year>2011</year>;<volume>59</volume>(<issue>5</issue>):<fpage>1</fpage>&#8211;<lpage>13</lpage>, 16.<pub-id pub-id-type="pmid">21553556</pub-id></mixed-citation></ref><ref id="phar70024-bib-0057"><label>57</label><mixed-citation publication-type="miscellaneous" id="phar70024-cit-0057"><collab collab-type="authors">Dailymed</collab>
. <article-title>Oxymorphone hydrochloride drug label</article-title>. <year>2024</year>. Updated 07/2024. Accessed October 28, 2024. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=22c7652a-aa16-4fa8-89d9-517e69059068" ext-link-type="uri">https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=22c7652a&#8208;aa16&#8208;4fa8&#8208;89d9&#8208;517e69059068</ext-link></mixed-citation></ref><ref id="phar70024-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="phar70024-cit-0058"><string-name name-style="western"><surname>Wieman</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Marinelli</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Ahdieh</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Gould</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Szmuk</surname><given-names>P</given-names></string-name>. <article-title>Safety, pharmacokinetics, and effectiveness of oxymorphone immediate release for acute pediatric postoperative pain</article-title>. <source>J Pain</source>. <year>2010</year>;<volume>11</volume>(<issue>4</issue>):<fpage>S50</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpain.2010.01.210</pub-id></mixed-citation></ref><ref id="phar70024-bib-0059"><label>59</label><mixed-citation publication-type="journal" id="phar70024-cit-0059"><string-name name-style="western"><surname>Wilfond</surname><given-names>BS</given-names></string-name>. <article-title>Pediatric drug labeling and imperfect information</article-title>. <source>Hastings Cent Rep</source>. <year>2020</year>;<volume>50</volume>(<issue>1</issue>):<fpage>3</fpage>. doi:<pub-id pub-id-type="doi">10.1002/hast.1074</pub-id><pub-id pub-id-type="pmid">32068277</pub-id></mixed-citation></ref><ref id="phar70024-bib-0060"><label>60</label><mixed-citation publication-type="journal" id="phar70024-cit-0060"><string-name name-style="western"><surname>Sauberan</surname><given-names>JB</given-names></string-name>, <string-name name-style="western"><surname>Anderson</surname><given-names>PO</given-names></string-name>, <string-name name-style="western"><surname>Lane</surname><given-names>JR</given-names></string-name>, et&#160;al. <article-title>Breast milk hydrocodone and hydromorphone levels in mothers using hydrocodone for postpartum pain</article-title>. <source>Obstet Gynecol</source>. <year>2011</year>;<volume>117</volume>(<issue>3</issue>):<fpage>611</fpage>&#8208;<lpage>617</lpage>. doi:<pub-id pub-id-type="doi">10.1097/AOG.0b013e31820ca504</pub-id><pub-id pub-id-type="pmid">21343764</pub-id></mixed-citation></ref><ref id="phar70024-bib-0061"><label>61</label><mixed-citation publication-type="journal" id="phar70024-cit-0061"><string-name name-style="western"><surname>Seaton</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Reeves</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>McLean</surname><given-names>S</given-names></string-name>. <article-title>Oxycodone as a component of multimodal analgesia for lactating mothers after caesarean section: relationships between maternal plasma, breast milk and neonatal plasma levels</article-title>. <source>Aust N Z J Obstet Gynaecol</source>. <year>2007</year>;<volume>47</volume>(<issue>3</issue>):<fpage>181</fpage>&#8208;<lpage>185</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1479-828X.2007.00715.x</pub-id><pub-id pub-id-type="pmid">17550483</pub-id></mixed-citation></ref><ref id="phar70024-bib-0062"><label>62</label><mixed-citation publication-type="journal" id="phar70024-cit-0062"><string-name name-style="western"><surname>Meny</surname><given-names>RG</given-names></string-name>, <string-name name-style="western"><surname>Naumburg</surname><given-names>EG</given-names></string-name>, <string-name name-style="western"><surname>Alger</surname><given-names>LS</given-names></string-name>, <string-name name-style="western"><surname>Brill&#8208;Miller</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Brown</surname><given-names>S</given-names></string-name>. <article-title>Codeine and the breastfed neonate</article-title>. <source>J Hum Lact</source>. <year>1993</year>;<volume>9</volume>(<issue>4</issue>):<fpage>237</fpage>&#8208;<lpage>240</lpage>. doi:<pub-id pub-id-type="doi">10.1177/089033449300900423</pub-id><pub-id pub-id-type="pmid">8260056</pub-id></mixed-citation></ref><ref id="phar70024-bib-0063"><label>63</label><mixed-citation publication-type="journal" id="phar70024-cit-0063"><string-name name-style="western"><surname>Wachman</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Byun</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Philipp</surname><given-names>BL</given-names></string-name>. <article-title>Breastfeeding rates among mothers of infants with neonatal abstinence syndrome</article-title>. <source>Breastfeed Med</source>. <year>2010</year>;<volume>5</volume>(<issue>4</issue>):<fpage>159</fpage>&#8208;<lpage>164</lpage>. doi:<pub-id pub-id-type="doi">10.1089/bfm.2009.0079</pub-id><pub-id pub-id-type="pmid">20658895</pub-id></mixed-citation></ref><ref id="phar70024-bib-0064"><label>64</label><mixed-citation publication-type="journal" id="phar70024-cit-0064"><string-name name-style="western"><surname>Welle&#8208;Strand</surname><given-names>GK</given-names></string-name>, <string-name name-style="western"><surname>Skurtveit</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Jansson</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Bakstad</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Bjarko</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Ravndal</surname><given-names>E</given-names></string-name>. <article-title>Breastfeeding reduces the need for withdrawal treatment in opioid&#8208;exposed infants</article-title>. <source>Acta Paediatr</source>. <year>2013</year>;<volume>102</volume>(<issue>11</issue>):<fpage>1060</fpage>&#8208;<lpage>1066</lpage>. doi:<pub-id pub-id-type="doi">10.1111/apa.12378</pub-id><pub-id pub-id-type="pmid">23909865</pub-id></mixed-citation></ref><ref id="phar70024-bib-0065"><label>65</label><mixed-citation publication-type="journal" id="phar70024-cit-0065"><string-name name-style="western"><surname>Fan</surname><given-names>HSL</given-names></string-name>, <string-name name-style="western"><surname>Wong</surname><given-names>JYH</given-names></string-name>, <string-name name-style="western"><surname>Fong</surname><given-names>DYT</given-names></string-name>, <string-name name-style="western"><surname>Lok</surname><given-names>KYW</given-names></string-name>, <string-name name-style="western"><surname>Tarrant</surname><given-names>M</given-names></string-name>. <article-title>Association between intrapartum factors and the time to breastfeeding initiation</article-title>. <source>Breastfeed Med</source>. <year>2020</year>;<volume>15</volume>(<issue>6</issue>):<fpage>394</fpage>&#8208;<lpage>400</lpage>. doi:<pub-id pub-id-type="doi">10.1089/bfm.2019.0166</pub-id><pub-id pub-id-type="pmid">32283038</pub-id></mixed-citation></ref><ref id="phar70024-bib-0066"><label>66</label><mixed-citation publication-type="journal" id="phar70024-cit-0066"><string-name name-style="western"><surname>Oommen</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Oddbjorn Tveit</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Eskedal</surname><given-names>LT</given-names></string-name>, <string-name name-style="western"><surname>Myr</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Swanson</surname><given-names>DM</given-names></string-name>, <string-name name-style="western"><surname>Vistad</surname><given-names>I</given-names></string-name>. <article-title>The association between intrapartum opioid fentanyl and early breastfeeding: a prospective observational study</article-title>. <source>Acta Obstet Gynecol Scand</source>. <year>2021</year>;<volume>100</volume>(<issue>12</issue>):<fpage>2294</fpage>&#8208;<lpage>2302</lpage>. doi:<pub-id pub-id-type="doi">10.1111/aogs.14268</pub-id><pub-id pub-id-type="pmid">34622936</pub-id></mixed-citation></ref><ref id="phar70024-bib-0067"><label>67</label><mixed-citation publication-type="journal" id="phar70024-cit-0067"><string-name name-style="western"><surname>Bakhireva</surname><given-names>LN</given-names></string-name>, <string-name name-style="western"><surname>Holbrook</surname><given-names>BD</given-names></string-name>, <string-name name-style="western"><surname>Shrestha</surname><given-names>S</given-names></string-name>, et&#160;al. <article-title>Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5&#8211;8 months of age</article-title>. <source>Early Hum Dev</source>. <year>2019</year>;<volume>128</volume>:<fpage>69</fpage>&#8208;<lpage>76</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.earlhumdev.2018.10.010</pub-id><pub-id pub-id-type="pmid">30554024</pub-id><pub-id pub-id-type="pmcid">PMC6348117</pub-id></mixed-citation></ref><ref id="phar70024-bib-0068"><label>68</label><mixed-citation publication-type="journal" id="phar70024-cit-0068"><string-name name-style="western"><surname>Azuine</surname><given-names>RE</given-names></string-name>, <string-name name-style="western"><surname>Ji</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>HY</given-names></string-name>, et&#160;al. <article-title>Prenatal risk factors and perinatal and postnatal outcomes associated with maternal opioid exposure in an urban, low&#8208;income, multiethnic US population</article-title>. <source>JAMA Netw Open</source>. <year>2019</year>;<volume>2</volume>(<issue>6</issue>):<elocation-id>e196405</elocation-id>. doi:<pub-id pub-id-type="doi">10.1001/jamanetworkopen.2019.6405</pub-id><pub-id pub-id-type="pmid">31251378</pub-id><pub-id pub-id-type="pmcid">PMC6604084</pub-id></mixed-citation></ref><ref id="phar70024-bib-0069"><label>69</label><mixed-citation publication-type="journal" id="phar70024-cit-0069"><string-name name-style="western"><surname>Garrison&#8208;Desany</surname><given-names>HM</given-names></string-name>, <string-name name-style="western"><surname>Hong</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Maher</surname><given-names>BS</given-names></string-name>, et&#160;al. <article-title>Individual and combined association between prenatal polysubstance exposure and childhood risk of attention&#8208;deficit/hyperactivity disorder</article-title>. <source>JAMA Netw Open</source>. <year>2022</year>;<volume>5</volume>(<issue>3</issue>):<elocation-id>e221957</elocation-id>. doi:<pub-id pub-id-type="doi">10.1001/jamanetworkopen.2022.1957</pub-id><pub-id pub-id-type="pmid">35275164</pub-id><pub-id pub-id-type="pmcid">PMC8917426</pub-id></mixed-citation></ref><ref id="phar70024-bib-0070"><label>70</label><mixed-citation publication-type="journal" id="phar70024-cit-0070"><string-name name-style="western"><surname>Miller</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Anderson</surname><given-names>JG</given-names></string-name>, <string-name name-style="western"><surname>Lindley</surname><given-names>LC</given-names></string-name>. <article-title>Behavioral development in children with prenatal substance exposure and neonatal abstinence syndrome: associated factors and implications</article-title>. <source>J Child Adolesc Psychiatr Nurs</source>. <year>2020</year>;<volume>33</volume>(<issue>2</issue>):<fpage>67</fpage>&#8208;<lpage>76</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jcap.12273</pub-id><pub-id pub-id-type="pmid">32275115</pub-id></mixed-citation></ref><ref id="phar70024-bib-0071"><label>71</label><mixed-citation publication-type="journal" id="phar70024-cit-0071"><string-name name-style="western"><surname>Brown</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Doshi</surname><given-names>PA</given-names></string-name>, <string-name name-style="western"><surname>Pauly</surname><given-names>NJ</given-names></string-name>, <string-name name-style="western"><surname>Talbert</surname><given-names>JC</given-names></string-name>. <article-title>Rates of neonatal abstinence syndrome amid efforts to combat the opioid abuse epidemic</article-title>. <source>JAMA Pediatr</source>. <year>2016</year>;<volume>170</volume>(<issue>11</issue>):<fpage>1110</fpage>&#8208;<lpage>1112</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jamapediatrics.2016.2150</pub-id><pub-id pub-id-type="pmid">27669331</pub-id><pub-id pub-id-type="pmcid">PMC5444666</pub-id></mixed-citation></ref><ref id="phar70024-bib-0072"><label>72</label><mixed-citation publication-type="journal" id="phar70024-cit-0072"><string-name name-style="western"><surname>Wang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Dave</surname><given-names>CV</given-names></string-name>, <string-name name-style="western"><surname>Alrwisan</surname><given-names>AA</given-names></string-name>, <string-name name-style="western"><surname>Voils</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Winterstein</surname><given-names>AG</given-names></string-name>. <article-title>Trends of neonatal abstinence syndrome epidemic and maternal risk factors in Florida</article-title>. <source>Pharmacotherapy</source>. <year>2017</year>;<volume>37</volume>(<issue>7</issue>):<fpage>806</fpage>&#8208;<lpage>813</lpage>. doi:<pub-id pub-id-type="doi">10.1002/phar.1947</pub-id><pub-id pub-id-type="pmid">28500694</pub-id></mixed-citation></ref><ref id="phar70024-bib-0073"><label>73</label><mixed-citation publication-type="journal" id="phar70024-cit-0073"><string-name name-style="western"><surname>Corr</surname><given-names>TE</given-names></string-name>, <string-name name-style="western"><surname>Xing</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>G</given-names></string-name>. <article-title>Longitudinal health care utilization of medicaid&#8208;insured children with a history of neonatal abstinence syndrome</article-title>. <source>J Pediatr</source>. <year>2021</year>;<volume>233</volume>:<fpage>82</fpage>&#8208;<lpage>89</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpeds.2021.01.067</pub-id>.e1.<pub-id pub-id-type="pmid">33545189</pub-id></mixed-citation></ref><ref id="phar70024-bib-0074"><label>74</label><mixed-citation publication-type="journal" id="phar70024-cit-0074"><string-name name-style="western"><surname>Danis</surname><given-names>DO</given-names><suffix>3rd</suffix></string-name>, <string-name name-style="western"><surname>Bachrach</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Piraquive</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Marston</surname><given-names>AP</given-names></string-name>, <string-name name-style="western"><surname>Levi</surname><given-names>JR</given-names></string-name>. <article-title>Cleft lip and palate in newborns diagnosed with neonatal abstinence syndrome</article-title>. <source>Otolaryngol Head Neck Surg</source>. <year>2021</year>;<volume>164</volume>(<issue>1</issue>):<fpage>199</fpage>&#8208;<lpage>205</lpage>. doi:<pub-id pub-id-type="doi">10.1177/0194599820944899</pub-id><pub-id pub-id-type="pmid">32689883</pub-id></mixed-citation></ref><ref id="phar70024-bib-0075"><label>75</label><mixed-citation publication-type="journal" id="phar70024-cit-0075"><string-name name-style="western"><surname>Hirai</surname><given-names>AH</given-names></string-name>, <string-name name-style="western"><surname>Ko</surname><given-names>JY</given-names></string-name>, <string-name name-style="western"><surname>Owens</surname><given-names>PL</given-names></string-name>, <string-name name-style="western"><surname>Stocks</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Patrick</surname><given-names>SW</given-names></string-name>. <article-title>Neonatal abstinence syndrome and maternal opioid&#8208;related diagnoses in the US, 2010&#8211;2017</article-title>. <source>JAMA</source>. <year>2021</year>;<volume>325</volume>(<issue>2</issue>):<fpage>146</fpage>&#8208;<lpage>155</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2020.24991</pub-id><pub-id pub-id-type="pmid">33433576</pub-id><pub-id pub-id-type="pmcid">PMC7804920</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>